SlideShare a Scribd company logo
Clinical Classification of Vascular Anomalies
Controversies and recent advances
Juan Carlos Lopez Gutierrez
Vascular Anomalies Center
La Paz Children´s Hospital
Simposio Internacional: Mosaicismo somático en malformaciones vasculares. Madrid, 10 y 11 de mayo de 2018
In 2018 , 50.000 children are expected to need treatment for a
Vascular Anomaly in Europe
ISSVA classification for vascular anomalies
(Approved at the 20th ISSVA Workshop, Melbourne, April 2014)
Overview table
°defined as two or more vascular malformations found in one lesion
* high-flow lesions
N.B. The classification tables do not list exhaustively all known vascular anomalies.
Some rare "dermatologic" vascular anomalies will be found in dermatology textbooks.
The tumor or malformation nature or precise classification of some lesions is still unclear.
These lesions appear in a separate provisional list.
Vascular anomalies
Vascular tumors Vascular malformations
Simple Combined °
of major named
vessels
associated with
other anomalies
Benign
Locally aggressive or
borderline
Malignant
Capillary malformations
Lymphatic malformations
Venous malformations
Arteriovenous malformations*
Arteriovenous fistula*
CVM, CLM
LVM, CLVM
CAVM*
CLAVM*
others
See details See list
For more details, click on
the underlined linksAbbreviations used
ISSVA classification of vascular tumors I
Benign vascular tumors
Infantile hemangioma / Hemangioma of infancy see details
Congenital hemangioma
Rapidly involuting (RICH) *, Non-involuting (NICH), Partially involuting (PICH)
Tufted angioma * °
Spindle-cell hemangioma
Intramuscular hemangioma (capillary type)
Epithelioid hemangioma
Pyogenic granuloma (aka lobular capillary hemangioma)
Others
Hobnail hemangioma
Microvenular hemangioma
Anastomosing hemangioma
Glomeruloid hemangioma
Papillary hemangioma
Intravascular papillary endothelial hyperplasia
Cutaneous epitheliod angiomatous nodule
Acquired elastotic hemangioma
Littoral cell hemangioma of the spleen
Related lesions
Eccrine angiomatous hamartoma
Reactive angioendotheliomatosis
Bacillary angiomatosis
Back to
overview
Type Alt 
for previous
view
* some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
°many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum
rather than distinct entities
N.B. reactive proliferative vascular lesions are listed with benign tumors
Benign vascular tumors
Congenital hemangioma GNAQ / GNA11
Rapidly involuting (RICH)
Non-involuting (NICH)
Partially involuting (PICH)
Tufted angioma GNA14
Epithelioid hemangioma FOS
Pyogenic granuloma BRAF / RAS / GNA14
Spindle-cell hemangioma IDH1 / IDH2
Locally aggressive or borderline vascular tumors
Kaposiform hemangioendothelioma t(13;16)(q14;p13.3) GNA14
Pseudomyogenic hemangioendothelioma t(7:19)(q22;13) / FOSB
Malignant vascular tumors
Angiosarcoma (post radiation) MYC
Epithelioid hemangioendothelioma CAMTA1 / TFE3
Back to
overview
Type Alt 
for previous
viewAppendix 2-a
causal genes of vascular anomalies
Capillary malformations (CM)
Cutaneous and/or mucosal CM (aka “port-wine” stain ) GNAQ
CM with bone and/or soft tissue hyperplasia GNA11
CM with CNS and/or ocular anomalies (Sturge-Weber syndrome) GNAQ
CM of CM-AVM RASA1 / EPHB4
Telangiectasia
Hereditary hemorrhagic telangiectasia (HHT)
HHT1 ENG
HHT2 ACVRL1
HHT3
JPHT (juvenile polyposis hemorrhagic telangiectasia) SMAD4
Others
Cutis marmorata telangiectatica congenita (CMTC)
Nevus simplex / Salmon patch
Others
Appendix 2-b
causal genes of vascular anomalies
Back to
overview
Type Alt 
for previous
view
Simple vascular malformations II
Lymphatic malformations (LM)
Common (cystic) LM PIK3CA somatic
Macrocystic LM
Microcystic LM
Mixed cystic LM
Generalized lymphatic anomaly (GLA)
LM in Gorham-Stout disease
Channel type LM
Primary lymphedema (different types) G
Acquired progressive lymphatic anomaly (acquired progressive "lymphangioma")
Others
Back to
overview
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
clic on G to see genetics
Type Alt 
for previous
viewAppendix 2-c
causal genes of vascular anomalies
Lymphatic malformations (LM)
Primary lymphedema
Nonne-Milroy syndrome
FLT4 / VEGFR3
Primary hereditary lymphedema VEGFC
Primary hereditary lymphedema GJC2 / Connexin 47
Lymphedema-distichiasis FOXC2
Hypotrichosis-lymphedema-telangiectasia SOX18
Primary lymphedema with myelodysplasia GATA2
Primary generalized lymphatic anomaly
(Hennekam lymphangiectasia-lymphedema syndrome) CCBE1
Microcephaly with or without chorioretinopathy,
lymphedema, or mental retardation syndrome KIF11
Lymphedema-choanal atresia PTPN14
Back to
overview Appendix 2-d
causal genes of vascular anomalies
Type Alt 
for previous
view
Venous malformations (VM)
Common VM TEK (TIE2) / PIK3CA somatic
Familial VM cutaneo-mucosal (VMCM) TEK (TIE2)
Blue rubber bleb nevus (Bean) syndrome VM TEK (TIE2) somatic
Glomuvenous malformation (VM with glomus cells) Glomulin
Cerebral cavernous malformation (CCM)
CCM1 KRIT1
CCM2 Malcavernin
CCM3 PDCD10
Familial intraosseous vascular malformation (VMOS) ELMO2
Back to
overview Appendix 2-e
causal genes of vascular anomalies
Type Alt 
for previous
view
Arteriovenous malformations (AVM)
Sporadic MAP2K1
In HHT
HHT1 ENG
HHT2 ACVRL1
JPHT (juvenile polyposis hem. telangiect.) SMAD4
In CM-AVM RASA1 / EPHB4
Arteriovenous fistulas (AVF)
Sporadic MAP2K1
In HHT
HHT1 ENG
HHT2 ACVRL1
JPHT (juvenile polyposis hemorrhagic telangiectasia) SMAD4
In CM-AVM RASA1 / EPHB4
Back to
overview Appendix 2-f
causal genes of vascular anomalies
Abbreviations used
Type Alt 
for previous
view
Back to
overview
Vascular malformations associated with other anomalies
Klippel-Trenaunay syndrome PIK3CA somatic
Parkes Weber syndrome RASA1
Servelle-Martorell syndrome
Sturge-Weber syndrome GNAQ
Limb CM + congenital non-progressive limb overgrowth GNA11
Maffucci syndrome IDH1 / IDH2
Macrocephaly - CM (M-CM or MCAP) PIK3CA
Microcephaly - CM (MICCAP) STAMBP
CLOVES syndrome PIK3CA somatic
Proteus syndrome AKT1
Bannayan-Riley-Ruvalcaba syndrome PTEN
CLAPO syndrome PIK3CA
Appendix 2-g
causal genes of vascular anomalies
Abbreviations used
Type Alt 
for previous
view
Provisionally unclassified vascular anomalies
Verrucous hemangioma / Verrucous VM / Verrucous LVM MAP3K3 somatic
Angiokeratoma
Sinusoidal hemangioma
Acral arteriovenous "tumour"
Multifocal lymphangioendotheliomatosis with thrombocytopenia / cutaneovisceral
angiomatosis with thrombocytopenia (MLT/CAT)
Kaposiform lymphangiomatosis (KLA)
PTEN (type) hamartoma of soft tissue / "angiomatosis" of soft tissue PTEN
Fibro adipose vascular anomaly (FAVA) PIK3CA
Back to
overview Appendix 2 -h
causal genes of vascular anomalies
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
Type Alt 
for previous
view
Appendix 3
infantile hemangioma
Back to
overview
Pattern
- focal
- multifocal
- segmental
- indeterminate
Different types
- superficial
- deep
- mixed (superficial + deep)
- reticular / abortive / minimal growth
- others
Association with other lesions
PHACE association /
syndrome
Posterior fossa malformations, Hemangioma, Arterial
anomalies, Cardiovascular anomalies, Eye anomalies,
sternal clefting and ⁄ or supraumbilical raphe
LUMBAR (SACRAL,
PELVIS) association /
syndrome
Lower body hemangioma, Urogenital anomalies,
Ulceration, Myelopathy, Bony deformities, Anorectal
malformations, Arterial anomalies, and Renal anomalies
Type Alt 
for previous
view
HYPER-PROLIFERATIVE HEMANGIOMAS
IH clinical course markers remain under investigation
IH clinical course is not classified and best propranolol timing
treatment protocols remain unavailable
FROM LIVER HEMANGIOENDOTHELIOMAS TO HEMANGIOMAS
• FOCAL..RICH ANALOG…GLUT1-
• MULTIFOCAL……….GLUT1+
• DIFFUSSE…………...GLUT1+
The United Network for Organ Sharing (UNOS) database recorded that a total of 35 children under 1 year of
age underwent liver transplantation between 1989 and 2008, because of hemangioma. In contrast, between
2009 and 2017, among 2672 children aged less than 1 year who underwent liver transplantation, none had a
diagnosis of hemangioma
RICH: Rapidly Involuting Congenital Hemangioma
ISSVA classification of vascular tumors II or 2
Locally aggressive or borderline vascular tumors
Kaposiform hemangioendothelioma * °
Retiform hemangioendothelioma
Papillary intralymphatic angioendothelioma (PILA), Dabska tumor
Composite hemangioendothelioma
Pseudomyogenic hemangioendothelioma G
Polymorphous hemangioendothelioma
Hemangioendothelioma not otherwise specified
Kaposi sarcoma
Others
Malignant vascular tumors
Angiosarcoma G
Epithelioid hemangioendothelioma G
Others
Back to
overview
* some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
°many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum
rather than distinct entities
N.B. reactive proliferative vascular lesions are listed with benign tumors
Type Alt 
for previous
view
KAPOSIFORM HEMANGIOENDOTHELIOMA
Rapamycin 0.8mg/m2/12h
The spectrum of disease varies greatly between
an indolent disease and aggressive disease with
widespread metastases.
Doyle LA, Fletcher CD, Hornick JL.Nuclear Expression of CAMTA1
Distinguishes Epithelioid Hemangioendothelioma From Histologic
Mimics. Am J Surg Pathol.2016 Jan;40(1):94-102
Uncertain biological behaviour of Composite , Retiform, Epithelioid Hemagioendotheliomas
Composite HE : Third recurrence episode
Dx: Composite Hemangioendothelioma
3 years later… metastatic disease
Similar clinical course in Pediatric and Adult EHE ?
Similar clinical course in liver , skin or pulmonary EHE?
Literature review identified 24 children with EHE of the liver/lungs.
Most presented with multifocal, systemic disease.
Four children experienced rapid progression and died.
In six children, disease remained stable for years without therapy.
Two patients died from progressive EHE 21 and 24 years after first
diagnosis.
Twelve surgically excised are free of disease
Natural evolution of pediatric visceral EHE is variable, and long-term
prognosis remains unclear
Hettmer S et al.
Epithelioid hemangioendotheliomas of the liver and lung in children and adolescents.
Pediatr Blood Cancer.2017 Dec;64(12)
Simple vascular malformations I
Capillary malformations (CM)
Cutaneous and/or mucosal CM (aka “port-wine” stain ) G
CM with bone and/or soft tissue overgrowth G
CM with CNS and/or ocular anomalies (Sturge-Weber syndrome)
CM of CM-AVM G
CM of MICCAP (microcephaly-capillary malformation)
CM of MCAP (megalencephaly-capillary malformation-polymicrogyria)
Telangiectasia
Hereditary hemorrhagic telangiectasia (HHT) (different types) G
Others
Cutis marmorata telangiectatica congenita (CMTC)
Nevus simplex / Salmon patch / “angel kiss”, “stork bite”
Others
ISSVA classification for vascular anomaliesBack to
overview
clic on G to see genetics
Type Alt 
for previous
view
Sturge-Weber Sme.
No seizures after 1 year under Sirolimus-AAS treatment
Better than expected response to Pulse Dye Laser treatment
MOST SEVERE PRESENTATION OF STURGE WEBER SME.
Simple vascular malformations II
Lymphatic malformations (LM)
Common (cystic) LM G
Macrocystic LM
Microcystic LM
Mixed cystic LM
Generalized lymphatic anomaly (GLA)
LM in Gorham-Stout disease
Channel type LM
Primary lymphedema (different types) G
ISSVA classification for vascular anomalies
Infiltration ? Invasion ? Proliferation ? Growth? Enlargement?
Dilatation ?
“Lymphangiomatosis is a rare disease characterized by diffuse infiltration of lymphangiomas in the lung,
bone, and other tissues………”
“Diffuse pulmonary lymphangiomatosis has a poor prognosis and is characterized by slow progressive
growth of lymphatic……..”
“Disseminated lymphangiomatosis is a rare vascular tumor characterized by a proliferation of abnormal
lymphatic channels that often involves multiple organ systems………………..”
“However, diffuse pulmonary lymphangiomatosis may present as a form of lymphangiectasia, which is
characterized pathologically as dilatations of lymphatics without proliferation and without an
anastomosing pattern……………………..”
AGRESSIVE LYMPHATIC MALFORMATIONS: A PROLIFERATIVE DISORDER ?
Meijer-Jorna LB et al. Microvascular proliferation in congenital vascular
malformations of skin and soft tissue J Clin Pathol. 2007 July; 60(7):
798–803.
“Proliferation does not happen in LM…….”
The presence of presumed lymphatic channels in bone that is either hypertrophic or
shows progressive disappearance is not associated with increased levels of cell
turnover or osteocyte activity ( Paula North, 1st GLA-GSD Conference.Bethesda 2013)
VEIN-LYMPHATIC CONNECTION and LYMPHATIC-LYMPHATIC CONNECTION
Bilateral LM in neonates have poor prognosis
8 months on Sirolimus
18 months on Sirolimus
CHANNEL TYPE LYMPHATIC MALFORMATIONS
Generalized
Lymphatic
Anomaly
Chylothorax
Chylous
Ascites
Spleen
Liver
Kidney
involvement
Osteolysis
Gorham Disease
Skin
involvement
Loosing
protein
enteropathy
Simple vascular malformations IIb
Primary lymphedema
Nonne-Milroy syndrome G
Primary hereditary lymphedema G
Lymphedema-distichiasis G
Hypotrichosis-lymphedema-telangiectasia G
Primary lymphedema with myelodysplasia G
Primary generalized lymphatic anomaly
(Hennekam lymphangiectasia-lymphedema syndrome) G
Microcephaly with or without chorioretinopathy,
lymphedema, or mental retardation syndrome G
Lymphedema-choanal atresia G
Back to
overview ISSVA classification for vascular anomalies
clic on G to see genetics
Type Alt 
for previous
view
Lymphedema-Distichiasis Syndrome.
Milroy Disease
Lymphedema in Sclerosis Tuberosa Complex
Lymphedema in Noonan Sme.
Lymphedema in Parkes-Weber Sme.
Simple vascular malformations III
Venous malformations (VM)
Common VM G
Familial VM cutaneo-mucosal (VMCM) G
Blue rubber bleb nevus (Bean) syndrome VM G
Glomuvenous malformation (GVM) G
Cerebral cavernous malformation (CCM) (different types) G
Familial intraosseous vascular malformation (VMOS) G
Others
ISSVA classification for vascular anomalies
Back to
overview
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
clic on G to see genetics
Type Alt 
for previous
view
Caso 1Lopez Gutierrez JC , Ivars M. Fern-shaped patch as a hallmark of blue rubber
bleb nevus syndrome in neonatal venous malformations
Eur J Pediatr. 2018 Mar 8.
Blue Rubber Bleb Nevus Syndrome
Tumor or Malformation ?
Verrucous lymphovascular malformation
Simple vascular malformations IV
Arteriovenous malformations (AVM)
Sporadic
In HHT G
In CM-AVM G
Others
Arteriovenous fistula (AVF) (congenital)
Sporadic
In HHT G
In CM-AVM G
Others
ISSVA classification for vascular anomalies
Back to
overview
Abbreviations used clic on G to see genetics
Type Alt 
for previous
view
Girón-Vallejo O, López-Gutiérrez JC, Fernández-Pineda I
Diagnosis and treatment of Parkes Weber syndrome: a review of 10 consecutive patients.
Ann Vasc Surg.2013 Aug;27(6):820-5.
2006
ISSVA classification for vascular anomalies
Combined vascular malformations*
CM + VM capillary-venous malformation CVM
CM + LM capillary-lymphatic malformation CLM
CM + AVM capillary-arteriovenous malformation CAVM
LM + VM lymphatic-venous malformation LVM
CM + LM + VM capillary-lymphatic-venous malformation CLVM
CM + LM + AVM capillary-lymphatic-arteriovenous malformation CLAVM
CM + VM + AVM capillary-venous-arteriovenous malformation CVAVM
CM + LM + VM + AVM capillary-lymphatic-venous-arteriovenous m. CLVAVM
Back to
overview
Abbreviations used
* defined as two or more vascular malformations found in one lesion
Type Alt 
for previous
view
MECHANISMS OF SKELETAL HYPERTROPHY OR ATROPHY IN COMBINED VASCULAR
MALFORMATIONS REMAIN UNEXPLAINED
Patients with PIK3CA mutations can develope overgrowth, simmetry and undergrowth
PTE stratification risk
ORAL PREPARATION FOR CHILDREN UNDER 35 KGS
0’05mg/kg/ 12h
0’4mgs/ml Solution
2´5 mgs tablet in 60ml 5% glucose
ISSVA classification for vascular anomalies
Back to
overview
Anomalies of major named vessels
(aka "channel type" or "truncal" vascular malformations)
Affect
lymphatics
veins
arteries
Anomalies of
origin
course
number
length
diameter (aplasia, hypoplasia, stenosis, ectasia / aneurysm)
valves
communication (AVF)
persistence (of embryonal vessel)
Abbreviations used
Type Alt 
for previous
view
TGF-β signaling is upregulated in many elastic fiber diseases including Loeys–Dietz, Marfan, and several
cutis laxa syndromes but the exact spatio-temporal regulation of TGF-β signaling remains a matter of
debate
Arterial Tortuosity Syndrome is caused by loss-of-function mutations in the SLC2A10 gene
ISSVA classification for vascular anomalies
Provisionally unclassified vascular anomalies
Verrucous hemangioma, V venous malformation, V veno lymphatic malformation G
Angiokeratoma
Sinusoidal hemangioma
Acral arteriovenous "tumour"
Multifocal lymphangioendotheliomatosis with thrombocytopenia / cutaneovisceral
angiomatosis with thrombocytopenia (MLT/CAT)
Kaposiform lymphangiomatosis (KLA)
PTEN (type) hamartoma of soft tissue / "angiomatosis" of soft tissue (PHOST) G
Fibro adipose vascular anomaly (FAVA) G
Back to
overview
clic on G to see genetics
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
Type Alt 
for previous
view
FAVA
Fibroadipous Vascular Anomalies
KAPOSIFORM LYMPHANGIOMATOSIS
Response to sirolimus
Sirolimus-responder VA´s Sirolimus-resistant VA´s
TO BE DIAGNOSED…………
CONCLUSIONS
Appropiate classification of a VA remains the best way to achieve the
expected therapeutical outcome
Multidisciplinary interpretation of findings from diagnostic
examinations is mandatory and will improve final results
A sense of wonder must guide research by the vascular anomalies
specialist as many entities remain to be identified , classified and
diagnosed.
ISSVA classification for vascular anomalies
Back to
overview
Vascular malformations associated with other anomalies
Klippel-Trenaunay syndrome: CM + VM +/- LM + limb overgrowth G
Parkes Weber syndrome: CM + AVF + limb overgrowth G
Servelle-Martorell syndrome: limb VM + bone undergrowth
Sturge-Weber syndrome: facial + leptomeningeal CM + eye anomalies
+/- bone and/or soft tissue overgrowth G
Limb CM + congenital non-progressive limb hypertrophy G
Maffucci syndrome: VM +/- spindle-cell hemangioma + enchondroma G
Macrocephaly - CM (M-CM / MCAP) G
Microcephaly - CM (MICCAP) G
CLOVES syndrome: LM + VM + CM +/- AVM + lipomatous overgrowth G
Proteus syndrome: CM, VM and/or LM + asymmetrical somatic overgrowth G
Bannayan-Riley-Ruvalcaba sd: AVM + VM +macrocephaly, lipomatous overgrowth G
CLAPO syndrome: lower lip CM + face and neck LM + asymmetry and
partial/generalized overgrowth
Abbreviations used clic on G to see genetics
Type Alt 
for previous
view
ISSVA classification for vascular anomalies
Provisionally unclassified vascular anomalies
Verrucous hemangioma, V venous malformation, V veno lymphatic malformation G
Angiokeratoma
Sinusoidal hemangioma
Acral arteriovenous "tumour"
Multifocal lymphangioendotheliomatosis with thrombocytopenia / cutaneovisceral
angiomatosis with thrombocytopenia (MLT/CAT)
Kaposiform lymphangiomatosis (KLA)
PTEN (type) hamartoma of soft tissue / "angiomatosis" of soft tissue (PHOST) G
Fibro adipose vascular anomaly (FAVA) G
Back to
overview
clic on G to see genetics
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
Type Alt 
for previous
view
Yang CH
Orthotopic liver transplant for
multifocal lymphangioendotheliomatosis with
thrombocytopenia.
Pediatr Transplant.2016 May;20(3):456-459.
Appendix 4
vascular anomalies
possibly associated with platelet count / coagulation disorders
Back to
overview
Anomalies Hematological disorders
Tufted angioma
Kaposiform hemangioendothelioma
Profound and sustained thrombocytopenia with profound
hypofibrinogenemia, consumptive coagulopathy and
elevated D-dimer (Kasabach-Merritt phenomenon)
Rapidly involuting congenital
hemangioma
Transient mild/moderate thrombocytopenia, +/-
consumptive coagulopathy and elevated D-dimer
Venous malformations /
Lymphatic-venous malformations
Chronic localized intravascular coagulopathy with
elevated D-dimer, +/- hypofibrinogenemia, and +/-
moderate thrombocytopenia
(may progress to DIC after trauma or operation)
Lymphatic malformations Chronic localized intravascular coagulopathy with
elevated D-dimer and +/- mild to moderate
thrombocytopenia
(consider Kaposiform lymphangiomatosis)
(may progress to DIC after trauma or operation)
Multifocal lymphangioendotheliomatosis
with thrombocytopenia /
Cutaneovisceral angiomatosis with
thrombocytopenia
Sustained, fluctuating, moderate to profound
thrombocytopenia with gastrointestinal tract bleeding or
pulmonary hemorrhage
Kaposiform lymphangiomatosis Mild to Moderate thrombocytopenia, +/-
hypofibrinogenemia, and D-dimer elevation
Type Alt 
for previous
view
Appendix 1
abbreviations used
(excluding gene names)
Back to
overview
AVF arteriovenous fistula
AVM arteriovenous malformation
CAT cutaneovisceral angiomatosis with thrombocytopenia
CAVM capillary arteriovenous malformation
CCM cerebral cavernous malformation
CLAVM capillary lymphatic arteriovenous malformation
CLAPO
lower lip CM + face and neck LM + asymmetry and
partial/generalized overgrowth
CLOVES
congenital lipomatous overgrowth, vascular
malformations, epidermal nevi, skeletal/scoliosis and
spinal abnormalities
CLM capillary lymphatic malformation
CLVAVM capillary lymphatic venous arteriovenous malformation
CLVM capillary lymphatic venous malformation
CM capillary malformation
CM-AVM capillary malformation-arteriovenous malformation
CMTC cutis marmorata telangiectatica congenita
CNS central nervous system
CVAVM capillary venous arteriovenous malformation
CVM capillary venous malformation
DIC disseminated intravascular coagulopathy
FAVA Fibro adipose vascular anomaly
GLA generalized lymphatic anomaly
GSD Gorham-Stout disease
GVM glomuvenous malformation
HHT hereditary hemorrhagic telangiectasia
HI hemangioma of infancy / infantile hemangioma
IH infantile hemangioma / hemangioma of infancy
INR international normalized ratio
JPHT juvenile polyposis hemorrhagic telangiectasia
KHE kaposiform hemangioendothelioma
KLA kaposiform lymphangiomatosis
KMP Kasabach-Merritt phenomenon,
LM lymphatic malformation
LVM lymphatic venous malformation
MCAP megalencephaly-capillary malformation-polymicrogyria
M-CM macrocephaly-capillary malformation
MICCAP microcephaly-capillary malformation
MLT
Multifocal lymphangioendotheliomatosis with
thrombocytopenia
NICH non-involuting congenital hemangioma
PHACE
posterior fossa malformations, hemangioma, arterial
anomalies, cardiovascular anomalies, eye anomalies
PHOST PTEN hamartoma of soft tissue
PILA papillary intralymphatic angioendothelioma
PICH partially involuting congenital hemangioma
RICH rapidly involuting congenital hemangioma
TA tufted angioma
VM venous malformation
VMCM venous malformation cutaneo mucosal
Type Alt 
for previous
view
Benign vascular tumors
Congenital hemangioma GNAQ / GNA11
Rapidly involuting (RICH) *
Non-involuting (NICH)
Partially involuting (PICH)
Epithelioid hemangioma FOS
Spindle-cell hemangioma IDH1 / IDH2
Locally aggressive or borderline vascular tumors
Kaposiform hemangioendothelioma t(13;16)(q14;p13.3)
Pseudomyogenic hemangioendothelioma t(7:19)(q22;13) FOSB
Malignant vascular tumors
Angiosarcoma (post radiation) MYC
Epithelioid hemangioendothelioma CAMTA1 / TFE3
Back to
overview
Type Alt 
for previous
viewAppendix 2-a
causal genes of vascular anomalies
Capillary malformations (CM)
Cutaneous and/or mucosal CM (aka “port-wine” stain ) GNAQ
CM with bone and/or soft tissue hyperplasia GNA11
CM with CNS and/or ocular anomalies (Sturge-Weber syndrome) GNAQ
CM of CM-AVM RASA1 / EPHB4
Telangiectasia
Hereditary hemorrhagic telangiectasia (HHT)
HHT1 ENG
HHT2 ACVRL1
HHT3
JPHT (juvenile polyposis hemorrhagic telangiectasia) SMAD4
Others
Cutis marmorata telangiectatica congenita (CMTC)
Nevus simplex / Salmon patch
Others
Appendix 2-b
causal genes of vascular anomalies
Back to
overview
Type Alt 
for previous
view
Simple vascular malformations II
Lymphatic malformations (LM)
Common (cystic) LM PIK3CA?
Macrocystic LM
Microcystic LM
Mixed cystic LM
Generalized lymphatic anomaly (GLA)
LM in Gorham-Stout disease
Channel type LM
Primary lymphedema (different types) G
Acquired progressive lymphatic anomaly (benign "lymphangioendothelioma")
Others
Back to
overview
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
clic on G to see genetics
Type Alt 
for previous
viewAppendix 2-c
causal genes of vascular anomalies
Lymphatic malformations (LM)
Primary lymphedema
Nonne-Milroy syndrome FLT4 / VEGFR3
Primary hereditary lymphedema VEGFC
Primary hereditary lymphedema GJC2 / Connexin 47
Lymphedema-distichiasis FOXC2
Hypotrichosis-lymphedema-telangiectasia SOX18
Primary lymphedema with myelodysplasia GATA2
Primary generalized lymphatic anomaly
(Hennekam lymphangiectasia-lymphedema syndrome) CCBE1
Microcephaly with or without chorioretinopathy,
lymphedema, or mental retardation syndrome KIF11
Lymphedema-choanal atresia PTPN14
Back to
overview Appendix 2-d
causal genes of vascular anomalies
Type Alt 
for previous
view
Venous malformations (VM)
Common VM TEK (TIE2) / PIK3CA somatic
Familial VM cutaneo-mucosal (VMCM) TEK (TIE2)
Blue rubber bleb nevus (Bean) syndrome VM TEK somatic
Glomuvenous malformation (VM with glomus cells) Glomulin
Cerebral cavernous malformation (CCM)
CCM1 KRIT1
CCM2 Malcavernin
CCM3 PDCD10
Familial intraosseous vascular malformation (VMOS) ELMO2
Back to
overview Appendix 2-e
causal genes of vascular anomalies
Type Alt 
for previous
view
Arteriovenous malformations (AVM)
Sporadic
In HHT
HHT1 ENG
HHT2 ACVRL1
JPHT (juvenile polyposis hem. telangiect.) SMAD4
In CM-AVM RASA1 / EPHB4
Arteriovenous fistulas (AVF)
Sporadic
In HHT
HHT1 ENG
HHT2 ACVRL1
JPHT (juvenile polyposis hemorrhagic telangiectasia) SMAD4
In CM-AVM RASA1 / EPHB4
Back to
overview Appendix 2-f
causal genes of vascular anomalies
Abbreviations used
Type Alt 
for previous
view
Back to
overview
Vascular malformations associated with other anomalies
Klippel-Trenaunay syndrome PIK3CA
Parkes Weber syndrome RASA1
Servelle-Martorell syndrome
Sturge-Weber syndrome GNAQ
Limb CM + congenital non-progressive limb overgrowth GNA11
Maffucci syndrome IDH1 / IDH2 / NPM1
Macrocephaly - CM (M-CM or MCAP) PIK3CA
Microcephaly - CM (MICCAP) STAMBP
CLOVES syndrome PIK3CA
Proteus syndrome AKT1
Bannayan-Riley-Ruvalcaba syndrome PTEN
CLAPO syndrome
Appendix 2-g
causal genes of vascular anomalies
Abbreviations used
Type Alt 
for previous
view
Provisionally unclassified vascular anomalies
Verrucous hemangioma / V venous malformation / V veno lymphatic malformation MAP3K3 somatic
Angiokeratoma
Sinusoidal hemangioma
Acral arteriovenous "tumour"
Multifocal lymphangioendotheliomatosis with thrombocytopenia / cutaneovisceral
angiomatosis with thrombocytopenia (MLT/CAT)
Kaposiform lymphangiomatosis (KLA)
PTEN (type) hamartoma of soft tissue / "angiomatosis" of soft tissue PTEN
Fibro adipose vascular anomaly PIK3CA
Back to
overview Appendix 2 -h
causal genes of vascular anomalies
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
Type Alt 
for previous
view
* some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
°many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum
rather than distinct entities
N.B. reactive proliferative vascular lesions are listed with benign tumors
ISSVA classification of vascular tumors 1a
Benign vascular tumors 1
Infantile hemangioma / Hemangioma of infancy see details
Congenital hemangioma G
Rapidly involuting (RICH) *
Non-involuting (NICH)
Partially involuting (PICH)
Tufted angioma * °
Spindle-cell hemangioma G
Intramuscular hemangioma (capillary type)
Epithelioid hemangioma G
Pyogenic granuloma (aka lobular capillary hemangioma)
Others see details
Back to
overview
Type Alt 
for previous
view
N.B. reactive proliferative vascular lesions are listed with benign tumors
ISSVA classification of vascular tumors 1b
Benign vascular tumors 2
Others
Honail hemangioma
Microvenular hemangioma
Anastomosing hemangioma
Glomeruloid hemangioma
Papillary hemangioma
Intravascular papillary endothelial hyperplasia
Cutaneous epitheliod angiomatous nodule
Acquired elastotic hemangioma
Littoral cell hemangioma of the spleen
Related lesions
Eccrine angiomatous hamartoma
Reactive angioendotheliomatosis
Bacillary angiomatosis
Back to
overview
Type Alt 
for previous
view
ISSVA classification for vascular anomalies
(Approved at the 20th ISSVA Workshop, Melbourne, April 2014)
Overview table
°defined as two or more vascular malformations found in one lesion
* high-flow lesions
N.B. The classification tables do not list exhaustively all known vascular anomalies.
Some rare "dermatologic" vascular anomalies will be found in dermatology textbooks.
The tumor or malformation nature or precise classification of some lesions is still unclear.
These lesions appear in a separate provisional list.
Vascular anomalies
Vascular tumors Vascular malformations
Simple Combined °
of major named
vessels
associated with
other anomalies
Benign
Locally aggressive or
borderline
Malignant
Capillary malformations
Lymphatic malformations
Venous malformations
Arteriovenous malformations*
Arteriovenous fistula*
CVM, CLM
LVM, CLVM
CAVM*
CLAVM*
others
See details See list
For more details, click on
the underlined linksAbbreviations used
* some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
°many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum
rather than distinct entities
N.B. reactive proliferative vascular lesions are listed with benign tumors
ISSVA classification of vascular tumors 1a
Benign vascular tumors 1
Infantile hemangioma / Hemangioma of infancy see details
Congenital hemangioma G
Rapidly involuting (RICH) *
Non-involuting (NICH)
Partially involuting (PICH)
Tufted angioma * °
Spindle-cell hemangioma G
Intramuscular hemangioma (capillary type)
Epithelioid hemangioma G
Pyogenic granuloma (aka lobular capillary hemangioma)
Others see details
Back to
overview
Type Alt 
for previous
view
N.B. reactive proliferative vascular lesions are listed with benign tumors
ISSVA classification of vascular tumors 1b
Benign vascular tumors 2
Others
Hobnail hemangioma
Microvenular hemangioma
Anastomosing hemangioma
Glomeruloid hemangioma
Papillary hemangioma
Intravascular papillary endothelial hyperplasia
Cutaneous epitheliod angiomatous nodule
Acquired elastotic hemangioma
Littoral cell hemangioma of the spleen
Related lesions
Eccrine angiomatous hamartoma
Reactive angioendotheliomatosis
Bacillary angiomatosis
Back to
overview
Type Alt 
for previous
view
ISSVA classification of vascular tumors I
Benign vascular tumors
Infantile hemangioma / Hemangioma of infancy see details
Congenital hemangioma
Rapidly involuting (RICH) *, Non-involuting (NICH), Partially involuting (PICH)
Tufted angioma * °
Spindle-cell hemangioma
Intramuscular hemangioma (capillary type)
Epithelioid hemangioma
Pyogenic granuloma (aka lobular capillary hemangioma)
Others
Honail hemangioma
Microvenular hemangioma
Anastomosing hemangioma
Glomeruloid hemangioma
Papillary hemangioma
Intravascular papillary endothelial hyperplasia
Cutaneous epitheliod angiomatous nodule
Acquired elastotic hemangioma
Littoral cell hemangioma of the spleen
Related lesions
Eccrine angiomatous hamartoma
Reactive angioendotheliomatosis
Bacillary angiomatosis
Back to
overview
Type Alt 
for previous
view
* some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
°many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum
rather than distinct entities
N.B. reactive proliferative vascular lesions are listed with benign tumors
ISSVA classification of vascular tumors II or 2
Locally aggressive or borderline vascular tumors
Kaposiform hemangioendothelioma * °
Retiform hemangioendothelioma
Papillary intralymphatic angioendothelioma (PILA), Dabska tumor
Composite hemangioendothelioma
Pseudomyogenic hemangioendothelioma G
Polymorphous hemangioendothelioma
Hemangioendothelioma not otherwise specified
Kaposi sarcoma
Others
Malignant vascular tumors
Angiosarcoma G
Epithelioid hemangioendothelioma G
Others
Back to
overview
* some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
°many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum
rather than distinct entities
N.B. reactive proliferative vascular lesions are listed with benign tumors
Type Alt 
for previous
view
Simple vascular malformations I
Capillary malformations (CM)
Cutaneous and/or mucosal CM (aka “port-wine” stain ) G
CM with bone and/or soft tissue overgrowth G
CM with CNS and/or ocular anomalies (Sturge-Weber syndrome)
CM of CM-AVM G
CM of MICCAP (microcephaly-capillary malformation)
CM of MCAP (megalencephaly-capillary malformation-polymicrogyria)
Telangiectasia
Hereditary hemorrhagic telangiectasia (HHT) (different types) G
Others
Cutis marmorata telangiectatica congenita (CMTC)
Nevus simplex / Salmon patch / “angel kiss”, “stork bite”
Others
ISSVA classification for vascular anomaliesBack to
overview
clic on G to see genetics
Type Alt 
for previous
view
Simple vascular malformations II
Lymphatic malformations (LM)
Common (cystic) LM G
Macrocystic LM
Microcystic LM
Mixed cystic LM
Generalized lymphatic anomaly (GLA)
LM in Gorham-Stout disease
Channel type LM
Primary lymphedema (different types) G
Acquired progressive lymphatic anomaly (benign "lymphangioendothelioma")
Others
ISSVA classification for vascular anomalies
Back to
overview
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
clic on G to see genetics
Type Alt 
for previous
view
Simple vascular malformations IIb
Primary lymphedema
Nonne-Milroy syndrome G
Primary hereditary lymphedema G
Lymphedema-distichiasis G
Hypotrichosis-lymphedema-telangiectasia G
Primary lymphedema with myelodysplasia G
Primary generalized lymphatic anomaly
(Hennekam lymphangiectasia-lymphedema syndrome) G
Microcephaly with or without chorioretinopathy,
lymphedema, or mental retardation syndrome G
Lymphedema-choanal atresia G
Back to
overview ISSVA classification for vascular anomalies
clic on G to see genetics
Type Alt 
for previous
view
Simple vascular malformations III
Venous malformations (VM)
Common VM G
Familial VM cutaneo-mucosal (VMCM) G
Blue rubber bleb nevus (Bean) syndrome VM G
Glomuvenous malformation (GVM) G
Cerebral cavernous malformation (CCM) (different types) G
Familial intraosseous vascular malformation (VMOS) G
Others
ISSVA classification for vascular anomalies
Back to
overview
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
clic on G to see genetics
Type Alt 
for previous
view
Simple vascular malformations IV
Arteriovenous malformations (AVM)
Sporadic
In HHT G
In CM-AVM G
Others
Arteriovenous fistula (AVF) (congenital)
Sporadic
In HHT G
In CM-AVM G
Others
ISSVA classification for vascular anomalies
Back to
overview
Abbreviations used clic on G to see genetics
Type Alt 
for previous
view
ISSVA classification for vascular anomalies
Combined vascular malformations*
CM + VM capillary-venous malformation CVM
CM + LM capillary-lymphatic malformation CLM
CM + AVM capillary-arteriovenous malformation CAVM
LM + VM lymphatic-venous malformation LVM
CM + LM + VM capillary-lymphatic-venous malformation CLVM
CM + LM + AVM capillary-lymphatic-arteriovenous malformation CLAVM
CM + VM + AVM capillary-venous-arteriovenous malformation CVAVM
CM + LM + VM + AVM capillary-lymphatic-venous-arteriovenous m. CLVAVM
Back to
overview
Abbreviations used
* defined as two or more vascular malformations found in one lesion
Type Alt 
for previous
view
ISSVA classification for vascular anomalies
Back to
overview
Anomalies of major named vessels
(aka "channel type" or "truncal" vascular malformations)
Affect
lymphatics
veins
arteries
Anomalies of
origin
course
number
length
diameter (aplasia, hypoplasia, stenosis, ectasia / aneurysm)
valves
communication (AVF)
persistence (of embryonal vessel)
Abbreviations used
Type Alt 
for previous
view
ISSVA classification for vascular anomalies
Back to
overview
Vascular malformations associated with other anomalies
Klippel-Trenaunay syndrome: CM + VM +/- LM + limb overgrowth G
Parkes Weber syndrome: CM + AVF + limb overgrowth G
Servelle-Martorell syndrome: limb VM + bone undergrowth
Sturge-Weber syndrome: facial + leptomeningeal CM + eye anomalies
+/- bone and/or soft tissue overgrowth G
Limb CM + congenital non-progressive limb hypertrophy G
Maffucci syndrome: VM +/- spindle-cell hemangioma + enchondroma G
Macrocephaly - CM (M-CM / MCAP) G
Microcephaly - CM (MICCAP) G
CLOVES syndrome: LM + VM + CM +/- AVM + lipomatous overgrowth G
Proteus syndrome: CM, VM and/or LM + asymmetrical somatic overgrowth G
Bannayan-Riley-Ruvalcaba sd: AVM + VM +macrocephaly, lipomatous overgrowth G
CLAPO syndrome: lower lip CM + face and neck LM + asymmetry and
partial/generalized overgrowth
Abbreviations used clic on G to see genetics
Type Alt 
for previous
view
Appendix 1
abbreviations used
(excluding gene names)
Back to
overview
AVF arteriovenous fistula
AVM arteriovenous malformation
CAT cutaneovisceral angiomatosis with thrombocytopenia
CAVM capillary arteriovenous malformation
CCM cerebral cavernous malformation
CLAVM capillary lymphatic arteriovenous malformation
CLAPO
lower lip CM + face and neck LM + asymmetry and
partial/generalized overgrowth
CLOVES
congenital lipomatous overgrowth, vascular
malformations, epidermal nevi, skeletal/scoliosis and
spinal abnormalities
CLM capillary lymphatic malformation
CLVAVM capillary lymphatic venous arteriovenous malformation
CLVM capillary lymphatic venous malformation
CM capillary malformation
CM-AVM capillary malformation-arteriovenous malformation
CMTC cutis marmorata telangiectatica congenita
CNS central nervous system
CVAVM capillary venous arteriovenous malformation
CVM capillary venous malformation
DIC disseminated intravascular coagulopathy
FAVA Fibro adipose vascular anomaly
GLA generalized lymphatic anomaly
GSD Gorham-Stout disease
GVM glomuvenous malformation
HHT hereditary hemorrhagic telangiectasia
HI hemangioma of infancy / infantile hemangioma
IH infantile hemangioma / hemangioma of infancy
INR international normalized ratio
JPHT juvenile polyposis hemorrhagic telangiectasia
KHE kaposiform hemangioendothelioma
KLA kaposiform lymphangiomatosis
KMP Kasabach-Merritt phenomenon,
LM lymphatic malformation
LVM lymphatic venous malformation
MCAP megalencephaly-capillary malformation-polymicrogyria
M-CM macrocephaly-capillary malformation
MICCAP microcephaly-capillary malformation
MLT
Multifocal lymphangioendotheliomatosis with
thrombocytopenia
NICH non-involuting congenital hemangioma
PHACE
posterior fossa malformations, hemangioma, arterial
anomalies, cardiovascular anomalies, eye anomalies
PHOST PTEN hamartoma of soft tissue
PILA papillary intralymphatic angioendothelioma
PICH partially involuting congenital hemangioma
RICH rapidly involuting congenital hemangioma
TA tufted angioma
VM venous malformation
VMCM venous malformation cutaneo mucosal
Type Alt 
for previous
view
Appendix 3
infantile hemangioma
Back to
overview
Pattern
- focal
- multifocal
- segmental
- indeterminate
Different types
- superficial
- deep
- mixed (superficial + deep)
- reticular / abortive / minimal growth
- others
Association with other lesions
PHACE association /
syndrome
Posterior fossa malformations, Hemangioma, Arterial
anomalies, Cardiovascular anomalies, Eye anomalies,
sternal clefting and ⁄ or supraumbilical raphe
LUMBAR (SACRAL,
PELVIS) association /
syndrome
Lower body hemangioma, Urogenital anomalies,
Ulceration, Myelopathy, Bony deformities, Anorectal
malformations, Arterial anomalies, and Renal anomalies
Type Alt 
for previous
view
Síndrome CLAPO
No response to Sirolimus
Response to Vincristine –Ticlopidine – Aspirine
and percutaneous biliary diversion
Triana PJ, Lopez Gutierrez JC Pancreatic Kaposiform Hemangioendothelioma Not
Responding to Sirolimus. European Journal of Pediatric Surgery. 2017;5(1).
Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Universitario La Paz. Madrid, España.
Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Universitario La Paz. Madrid, España.
Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Universitario La Paz. Madrid, España.
Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Universitario La Paz. Madrid, España.

More Related Content

What's hot

Uk glanzmann
Uk glanzmannUk glanzmann
Uk glanzmann
MEDICINE VALE´S
 
ARVD
ARVDARVD
ARVD
Iqbal Dar
 
Hemophilia talk
Hemophilia talkHemophilia talk
Hemophilia talk
Muhammad Aizat Sofian
 
Recurrence of Klippel-Trenaunay syndrome symptoms after surgery: a single cas...
Recurrence of Klippel-Trenaunay syndrome symptoms after surgery: a single cas...Recurrence of Klippel-Trenaunay syndrome symptoms after surgery: a single cas...
Recurrence of Klippel-Trenaunay syndrome symptoms after surgery: a single cas...
Maurizio Ronconi
 
VTE VENOUS THROMBOEMBOLISM
VTE VENOUS THROMBOEMBOLISMVTE VENOUS THROMBOEMBOLISM
VTE VENOUS THROMBOEMBOLISM
AHMED AWADELKARIM
 
Pathophysiology of thromobosis and mana
Pathophysiology of thromobosis and manaPathophysiology of thromobosis and mana
Pathophysiology of thromobosis and manaderosaMSKCC
 
Vasculitis
VasculitisVasculitis
Vasculitis
Tajul Nisa
 
Hemophilia..pptx
Hemophilia..pptxHemophilia..pptx
Hemophilia..pptx
Elvidawati
 
Approach to a patient with vasculitis and its
Approach to a patient with vasculitis and itsApproach to a patient with vasculitis and its
Approach to a patient with vasculitis and its
Mohit Aggarwal
 
DVT & PTE
DVT &  PTEDVT &  PTE
DVT & PTE
GANESH MURKUT
 
Tumores cardiacos
Tumores cardiacosTumores cardiacos
Tumores cardiacos
Abraham Flores
 
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
Fundación Ramón Areces
 
Vasculitis 2015 undergraduate
Vasculitis 2015 undergraduateVasculitis 2015 undergraduate
Vasculitis 2015 undergraduate
Faculty of Medicine, Ain Shams University
 
Dvt prophylaxis
Dvt prophylaxisDvt prophylaxis
Dvt prophylaxisredaahmed
 
Deep Vein Thrombosis
Deep Vein ThrombosisDeep Vein Thrombosis
Deep Vein Thrombosis
bbthapa
 
Pediatric vasculitides
Pediatric vasculitidesPediatric vasculitides
Pediatric vasculitidesdattasrisaila
 
Systematization and diagnosis of vasculitides. Mikhail Valivach
Systematization and diagnosis of vasculitides. Mikhail ValivachSystematization and diagnosis of vasculitides. Mikhail Valivach
Systematization and diagnosis of vasculitides. Mikhail Valivach
Mikhail Valivach
 

What's hot (20)

Uk glanzmann
Uk glanzmannUk glanzmann
Uk glanzmann
 
ARVD
ARVDARVD
ARVD
 
Hemophilia talk
Hemophilia talkHemophilia talk
Hemophilia talk
 
123 coronary dialsysis
123 coronary dialsysis123 coronary dialsysis
123 coronary dialsysis
 
Recurrence of Klippel-Trenaunay syndrome symptoms after surgery: a single cas...
Recurrence of Klippel-Trenaunay syndrome symptoms after surgery: a single cas...Recurrence of Klippel-Trenaunay syndrome symptoms after surgery: a single cas...
Recurrence of Klippel-Trenaunay syndrome symptoms after surgery: a single cas...
 
VTE VENOUS THROMBOEMBOLISM
VTE VENOUS THROMBOEMBOLISMVTE VENOUS THROMBOEMBOLISM
VTE VENOUS THROMBOEMBOLISM
 
Pathophysiology of thromobosis and mana
Pathophysiology of thromobosis and manaPathophysiology of thromobosis and mana
Pathophysiology of thromobosis and mana
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Hemophilia..pptx
Hemophilia..pptxHemophilia..pptx
Hemophilia..pptx
 
Approach to a patient with vasculitis and its
Approach to a patient with vasculitis and itsApproach to a patient with vasculitis and its
Approach to a patient with vasculitis and its
 
DVT & PTE
DVT &  PTEDVT &  PTE
DVT & PTE
 
Tumores cardiacos
Tumores cardiacosTumores cardiacos
Tumores cardiacos
 
Aneurismas de la vena de galeno
Aneurismas de la vena de galenoAneurismas de la vena de galeno
Aneurismas de la vena de galeno
 
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
 
Vasculitis 2015 undergraduate
Vasculitis 2015 undergraduateVasculitis 2015 undergraduate
Vasculitis 2015 undergraduate
 
Dvt prophylaxis
Dvt prophylaxisDvt prophylaxis
Dvt prophylaxis
 
Deep Vein Thrombosis
Deep Vein ThrombosisDeep Vein Thrombosis
Deep Vein Thrombosis
 
Pediatric vasculitides
Pediatric vasculitidesPediatric vasculitides
Pediatric vasculitides
 
Tutorial vasculitis
Tutorial vasculitisTutorial vasculitis
Tutorial vasculitis
 
Systematization and diagnosis of vasculitides. Mikhail Valivach
Systematization and diagnosis of vasculitides. Mikhail ValivachSystematization and diagnosis of vasculitides. Mikhail Valivach
Systematization and diagnosis of vasculitides. Mikhail Valivach
 

Similar to Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Universitario La Paz. Madrid, España.

Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...
Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...
Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...
Mikhail Valivach
 
NON MELANOTIC 2.pdf
NON MELANOTIC 2.pdfNON MELANOTIC 2.pdf
NON MELANOTIC 2.pdf
MohamedBayoumi58
 
VASCULAR MALFORMATION AND ITS MANAGEMENT.pptx
VASCULAR MALFORMATION AND ITS MANAGEMENT.pptxVASCULAR MALFORMATION AND ITS MANAGEMENT.pptx
VASCULAR MALFORMATION AND ITS MANAGEMENT.pptx
DEBRAJ SAMANTA
 
Bleeding-disorders third year.pptx
Bleeding-disorders third year.pptxBleeding-disorders third year.pptx
Bleeding-disorders third year.pptx
ssuser9976be
 
Etiopathogenesis of Renal Tumors.pptx
Etiopathogenesis of Renal Tumors.pptxEtiopathogenesis of Renal Tumors.pptx
Etiopathogenesis of Renal Tumors.pptx
Anees Puthawala
 
5. bleeding disorder
5. bleeding disorder5. bleeding disorder
5. bleeding disorder
Whiteraven68
 
Approach to bleeding disorder (coagulation defects) in children
Approach to bleeding disorder (coagulation defects) in childrenApproach to bleeding disorder (coagulation defects) in children
Approach to bleeding disorder (coagulation defects) in children
Satish Vadapalli
 
Approach to bleeding child
Approach to bleeding childApproach to bleeding child
Approach to bleeding child
Dr M Sanjeevappa
 
Anaesthesia for ehpvo and lieno renal shunt
Anaesthesia for ehpvo and lieno renal shuntAnaesthesia for ehpvo and lieno renal shunt
Anaesthesia for ehpvo and lieno renal shunt
Dr. Ravikiran H M Gowda
 
Arrythmogenic rv dysplasia (ARVD)
Arrythmogenic rv dysplasia (ARVD)Arrythmogenic rv dysplasia (ARVD)
Arrythmogenic rv dysplasia (ARVD)
Sruthi Meenaxshi
 
Acute smv thrombosis
Acute smv thrombosisAcute smv thrombosis
Acute smv thrombosis
Mai Parachy
 
Approach to bleeding disorders part 1
Approach to bleeding disorders part 1Approach to bleeding disorders part 1
Approach to bleeding disorders part 1
drbcnayak
 
Treatable diseases using Stem Cells
Treatable diseases using Stem CellsTreatable diseases using Stem Cells
Treatable diseases using Stem Cells
Sararajputsa
 
Treatable Diseases Using Stem Cells
Treatable Diseases Using Stem CellsTreatable Diseases Using Stem Cells
Treatable Diseases Using Stem Cells
Ankita-rastogi
 
Treatable diseases using Stem Cells
Treatable diseases using Stem CellsTreatable diseases using Stem Cells
Treatable diseases using Stem Cells
Ankita-rastogi
 
Treatable Diseases Using Stem Cells
Treatable Diseases Using Stem CellsTreatable Diseases Using Stem Cells
Treatable Diseases Using Stem Cells
Sararajputsa
 

Similar to Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Universitario La Paz. Madrid, España. (20)

CME: Bleeding Disorders - Clinical Features
CME: Bleeding Disorders - Clinical FeaturesCME: Bleeding Disorders - Clinical Features
CME: Bleeding Disorders - Clinical Features
 
Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...
Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...
Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...
 
NON MELANOTIC 2.pdf
NON MELANOTIC 2.pdfNON MELANOTIC 2.pdf
NON MELANOTIC 2.pdf
 
VASCULAR MALFORMATION AND ITS MANAGEMENT.pptx
VASCULAR MALFORMATION AND ITS MANAGEMENT.pptxVASCULAR MALFORMATION AND ITS MANAGEMENT.pptx
VASCULAR MALFORMATION AND ITS MANAGEMENT.pptx
 
Bleeding-disorders third year.pptx
Bleeding-disorders third year.pptxBleeding-disorders third year.pptx
Bleeding-disorders third year.pptx
 
Etiopathogenesis of Renal Tumors.pptx
Etiopathogenesis of Renal Tumors.pptxEtiopathogenesis of Renal Tumors.pptx
Etiopathogenesis of Renal Tumors.pptx
 
Cmp
CmpCmp
Cmp
 
Arrhythmogenic right ventricular 2003
Arrhythmogenic right ventricular 2003Arrhythmogenic right ventricular 2003
Arrhythmogenic right ventricular 2003
 
5. bleeding disorder
5. bleeding disorder5. bleeding disorder
5. bleeding disorder
 
Approach to bleeding disorder (coagulation defects) in children
Approach to bleeding disorder (coagulation defects) in childrenApproach to bleeding disorder (coagulation defects) in children
Approach to bleeding disorder (coagulation defects) in children
 
Approach to bleeding child
Approach to bleeding childApproach to bleeding child
Approach to bleeding child
 
Anaesthesia for ehpvo and lieno renal shunt
Anaesthesia for ehpvo and lieno renal shuntAnaesthesia for ehpvo and lieno renal shunt
Anaesthesia for ehpvo and lieno renal shunt
 
Arrythmogenic rv dysplasia (ARVD)
Arrythmogenic rv dysplasia (ARVD)Arrythmogenic rv dysplasia (ARVD)
Arrythmogenic rv dysplasia (ARVD)
 
Hemostasis
HemostasisHemostasis
Hemostasis
 
Acute smv thrombosis
Acute smv thrombosisAcute smv thrombosis
Acute smv thrombosis
 
Approach to bleeding disorders part 1
Approach to bleeding disorders part 1Approach to bleeding disorders part 1
Approach to bleeding disorders part 1
 
Treatable diseases using Stem Cells
Treatable diseases using Stem CellsTreatable diseases using Stem Cells
Treatable diseases using Stem Cells
 
Treatable Diseases Using Stem Cells
Treatable Diseases Using Stem CellsTreatable Diseases Using Stem Cells
Treatable Diseases Using Stem Cells
 
Treatable diseases using Stem Cells
Treatable diseases using Stem CellsTreatable diseases using Stem Cells
Treatable diseases using Stem Cells
 
Treatable Diseases Using Stem Cells
Treatable Diseases Using Stem CellsTreatable Diseases Using Stem Cells
Treatable Diseases Using Stem Cells
 

More from Fundación Ramón Areces

Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Fundación Ramón Areces
 
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
Fundación Ramón Areces
 
Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London. Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London.
Fundación Ramón Areces
 
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Fundación Ramón Areces
 
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Fundación Ramón Areces
 
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI). Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Fundación Ramón Areces
 
Martín Uribe - Universidad de Columbia.
Martín Uribe - Universidad de Columbia.Martín Uribe - Universidad de Columbia.
Martín Uribe - Universidad de Columbia.
Fundación Ramón Areces
 
Thomas S. Robertson - The Wharton School.
Thomas S. Robertson - The Wharton School. Thomas S. Robertson - The Wharton School.
Thomas S. Robertson - The Wharton School.
Fundación Ramón Areces
 
Diana Robertson - The Wharton School.
Diana Robertson - The Wharton School. Diana Robertson - The Wharton School.
Diana Robertson - The Wharton School.
Fundación Ramón Areces
 
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Fundación Ramón Areces
 
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research. Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Fundación Ramón Areces
 
Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster. Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster.
Fundación Ramón Areces
 
Mercedes Ayuso - Universitat de Barcelona.
Mercedes Ayuso -  Universitat de Barcelona. Mercedes Ayuso -  Universitat de Barcelona.
Mercedes Ayuso - Universitat de Barcelona.
Fundación Ramón Areces
 
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics. Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Fundación Ramón Areces
 
Julia Campa - The Open University.
Julia Campa - The Open University. Julia Campa - The Open University.
Julia Campa - The Open University.
Fundación Ramón Areces
 
Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico. Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico.
Fundación Ramón Areces
 
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Fundación Ramón Areces
 
Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven. Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven.
Fundación Ramón Areces
 
Víctor R. de la Rosa - Investigador en Universiteit Gent (UGent) y fundador d...
Víctor R. de la Rosa - Investigador en Universiteit Gent (UGent) y fundador d...Víctor R. de la Rosa - Investigador en Universiteit Gent (UGent) y fundador d...
Víctor R. de la Rosa - Investigador en Universiteit Gent (UGent) y fundador d...
Fundación Ramón Areces
 
Sara Serrano - European Research Council (ERC).
Sara Serrano - European Research Council (ERC). Sara Serrano - European Research Council (ERC).
Sara Serrano - European Research Council (ERC).
Fundación Ramón Areces
 

More from Fundación Ramón Areces (20)

Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
 
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
 
Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London. Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London.
 
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
 
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
 
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI). Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
 
Martín Uribe - Universidad de Columbia.
Martín Uribe - Universidad de Columbia.Martín Uribe - Universidad de Columbia.
Martín Uribe - Universidad de Columbia.
 
Thomas S. Robertson - The Wharton School.
Thomas S. Robertson - The Wharton School. Thomas S. Robertson - The Wharton School.
Thomas S. Robertson - The Wharton School.
 
Diana Robertson - The Wharton School.
Diana Robertson - The Wharton School. Diana Robertson - The Wharton School.
Diana Robertson - The Wharton School.
 
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
 
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research. Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
 
Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster. Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster.
 
Mercedes Ayuso - Universitat de Barcelona.
Mercedes Ayuso -  Universitat de Barcelona. Mercedes Ayuso -  Universitat de Barcelona.
Mercedes Ayuso - Universitat de Barcelona.
 
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics. Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
 
Julia Campa - The Open University.
Julia Campa - The Open University. Julia Campa - The Open University.
Julia Campa - The Open University.
 
Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico. Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico.
 
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
 
Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven. Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven.
 
Víctor R. de la Rosa - Investigador en Universiteit Gent (UGent) y fundador d...
Víctor R. de la Rosa - Investigador en Universiteit Gent (UGent) y fundador d...Víctor R. de la Rosa - Investigador en Universiteit Gent (UGent) y fundador d...
Víctor R. de la Rosa - Investigador en Universiteit Gent (UGent) y fundador d...
 
Sara Serrano - European Research Council (ERC).
Sara Serrano - European Research Council (ERC). Sara Serrano - European Research Council (ERC).
Sara Serrano - European Research Council (ERC).
 

Recently uploaded

insect taxonomy importance systematics and classification
insect taxonomy importance systematics and classificationinsect taxonomy importance systematics and classification
insect taxonomy importance systematics and classification
anitaento25
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
insect morphology and physiology of insect
insect morphology and physiology of insectinsect morphology and physiology of insect
insect morphology and physiology of insect
anitaento25
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
sachin783648
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
muralinath2
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
SAMIR PANDA
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SELF-EXPLANATORY
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
pablovgd
 
Anemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditionsAnemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditions
muralinath2
 
Structural Classification Of Protein (SCOP)
Structural Classification Of Protein  (SCOP)Structural Classification Of Protein  (SCOP)
Structural Classification Of Protein (SCOP)
aishnasrivastava
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Sérgio Sacani
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
kumarmathi863
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
Lokesh Patil
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
muralinath2
 
Penicillin...........................pptx
Penicillin...........................pptxPenicillin...........................pptx
Penicillin...........................pptx
Cherry
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
plant biotechnology Lecture note ppt.pptx
plant biotechnology Lecture note ppt.pptxplant biotechnology Lecture note ppt.pptx
plant biotechnology Lecture note ppt.pptx
yusufzako14
 
EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
AlguinaldoKong
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
Health Advances
 
filosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptxfilosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptx
IvanMallco1
 

Recently uploaded (20)

insect taxonomy importance systematics and classification
insect taxonomy importance systematics and classificationinsect taxonomy importance systematics and classification
insect taxonomy importance systematics and classification
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
insect morphology and physiology of insect
insect morphology and physiology of insectinsect morphology and physiology of insect
insect morphology and physiology of insect
 
Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
 
Seminar of U.V. Spectroscopy by SAMIR PANDA
 Seminar of U.V. Spectroscopy by SAMIR PANDA Seminar of U.V. Spectroscopy by SAMIR PANDA
Seminar of U.V. Spectroscopy by SAMIR PANDA
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
 
Anemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditionsAnemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditions
 
Structural Classification Of Protein (SCOP)
Structural Classification Of Protein  (SCOP)Structural Classification Of Protein  (SCOP)
Structural Classification Of Protein (SCOP)
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
 
Structures and textures of metamorphic rocks
Structures and textures of metamorphic rocksStructures and textures of metamorphic rocks
Structures and textures of metamorphic rocks
 
Nutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technologyNutraceutical market, scope and growth: Herbal drug technology
Nutraceutical market, scope and growth: Herbal drug technology
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
 
Penicillin...........................pptx
Penicillin...........................pptxPenicillin...........................pptx
Penicillin...........................pptx
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
plant biotechnology Lecture note ppt.pptx
plant biotechnology Lecture note ppt.pptxplant biotechnology Lecture note ppt.pptx
plant biotechnology Lecture note ppt.pptx
 
EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
 
filosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptxfilosofia boliviana introducción jsjdjd.pptx
filosofia boliviana introducción jsjdjd.pptx
 

Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Universitario La Paz. Madrid, España.

  • 1. Clinical Classification of Vascular Anomalies Controversies and recent advances Juan Carlos Lopez Gutierrez Vascular Anomalies Center La Paz Children´s Hospital Simposio Internacional: Mosaicismo somático en malformaciones vasculares. Madrid, 10 y 11 de mayo de 2018
  • 2.
  • 3. In 2018 , 50.000 children are expected to need treatment for a Vascular Anomaly in Europe
  • 4.
  • 5. ISSVA classification for vascular anomalies (Approved at the 20th ISSVA Workshop, Melbourne, April 2014) Overview table °defined as two or more vascular malformations found in one lesion * high-flow lesions N.B. The classification tables do not list exhaustively all known vascular anomalies. Some rare "dermatologic" vascular anomalies will be found in dermatology textbooks. The tumor or malformation nature or precise classification of some lesions is still unclear. These lesions appear in a separate provisional list. Vascular anomalies Vascular tumors Vascular malformations Simple Combined ° of major named vessels associated with other anomalies Benign Locally aggressive or borderline Malignant Capillary malformations Lymphatic malformations Venous malformations Arteriovenous malformations* Arteriovenous fistula* CVM, CLM LVM, CLVM CAVM* CLAVM* others See details See list For more details, click on the underlined linksAbbreviations used
  • 6. ISSVA classification of vascular tumors I Benign vascular tumors Infantile hemangioma / Hemangioma of infancy see details Congenital hemangioma Rapidly involuting (RICH) *, Non-involuting (NICH), Partially involuting (PICH) Tufted angioma * ° Spindle-cell hemangioma Intramuscular hemangioma (capillary type) Epithelioid hemangioma Pyogenic granuloma (aka lobular capillary hemangioma) Others Hobnail hemangioma Microvenular hemangioma Anastomosing hemangioma Glomeruloid hemangioma Papillary hemangioma Intravascular papillary endothelial hyperplasia Cutaneous epitheliod angiomatous nodule Acquired elastotic hemangioma Littoral cell hemangioma of the spleen Related lesions Eccrine angiomatous hamartoma Reactive angioendotheliomatosis Bacillary angiomatosis Back to overview Type Alt  for previous view * some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details °many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum rather than distinct entities N.B. reactive proliferative vascular lesions are listed with benign tumors
  • 7. Benign vascular tumors Congenital hemangioma GNAQ / GNA11 Rapidly involuting (RICH) Non-involuting (NICH) Partially involuting (PICH) Tufted angioma GNA14 Epithelioid hemangioma FOS Pyogenic granuloma BRAF / RAS / GNA14 Spindle-cell hemangioma IDH1 / IDH2 Locally aggressive or borderline vascular tumors Kaposiform hemangioendothelioma t(13;16)(q14;p13.3) GNA14 Pseudomyogenic hemangioendothelioma t(7:19)(q22;13) / FOSB Malignant vascular tumors Angiosarcoma (post radiation) MYC Epithelioid hemangioendothelioma CAMTA1 / TFE3 Back to overview Type Alt  for previous viewAppendix 2-a causal genes of vascular anomalies
  • 8. Capillary malformations (CM) Cutaneous and/or mucosal CM (aka “port-wine” stain ) GNAQ CM with bone and/or soft tissue hyperplasia GNA11 CM with CNS and/or ocular anomalies (Sturge-Weber syndrome) GNAQ CM of CM-AVM RASA1 / EPHB4 Telangiectasia Hereditary hemorrhagic telangiectasia (HHT) HHT1 ENG HHT2 ACVRL1 HHT3 JPHT (juvenile polyposis hemorrhagic telangiectasia) SMAD4 Others Cutis marmorata telangiectatica congenita (CMTC) Nevus simplex / Salmon patch Others Appendix 2-b causal genes of vascular anomalies Back to overview Type Alt  for previous view
  • 9. Simple vascular malformations II Lymphatic malformations (LM) Common (cystic) LM PIK3CA somatic Macrocystic LM Microcystic LM Mixed cystic LM Generalized lymphatic anomaly (GLA) LM in Gorham-Stout disease Channel type LM Primary lymphedema (different types) G Acquired progressive lymphatic anomaly (acquired progressive "lymphangioma") Others Back to overview some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details clic on G to see genetics Type Alt  for previous viewAppendix 2-c causal genes of vascular anomalies
  • 10. Lymphatic malformations (LM) Primary lymphedema Nonne-Milroy syndrome FLT4 / VEGFR3 Primary hereditary lymphedema VEGFC Primary hereditary lymphedema GJC2 / Connexin 47 Lymphedema-distichiasis FOXC2 Hypotrichosis-lymphedema-telangiectasia SOX18 Primary lymphedema with myelodysplasia GATA2 Primary generalized lymphatic anomaly (Hennekam lymphangiectasia-lymphedema syndrome) CCBE1 Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome KIF11 Lymphedema-choanal atresia PTPN14 Back to overview Appendix 2-d causal genes of vascular anomalies Type Alt  for previous view
  • 11. Venous malformations (VM) Common VM TEK (TIE2) / PIK3CA somatic Familial VM cutaneo-mucosal (VMCM) TEK (TIE2) Blue rubber bleb nevus (Bean) syndrome VM TEK (TIE2) somatic Glomuvenous malformation (VM with glomus cells) Glomulin Cerebral cavernous malformation (CCM) CCM1 KRIT1 CCM2 Malcavernin CCM3 PDCD10 Familial intraosseous vascular malformation (VMOS) ELMO2 Back to overview Appendix 2-e causal genes of vascular anomalies Type Alt  for previous view
  • 12. Arteriovenous malformations (AVM) Sporadic MAP2K1 In HHT HHT1 ENG HHT2 ACVRL1 JPHT (juvenile polyposis hem. telangiect.) SMAD4 In CM-AVM RASA1 / EPHB4 Arteriovenous fistulas (AVF) Sporadic MAP2K1 In HHT HHT1 ENG HHT2 ACVRL1 JPHT (juvenile polyposis hemorrhagic telangiectasia) SMAD4 In CM-AVM RASA1 / EPHB4 Back to overview Appendix 2-f causal genes of vascular anomalies Abbreviations used Type Alt  for previous view
  • 13. Back to overview Vascular malformations associated with other anomalies Klippel-Trenaunay syndrome PIK3CA somatic Parkes Weber syndrome RASA1 Servelle-Martorell syndrome Sturge-Weber syndrome GNAQ Limb CM + congenital non-progressive limb overgrowth GNA11 Maffucci syndrome IDH1 / IDH2 Macrocephaly - CM (M-CM or MCAP) PIK3CA Microcephaly - CM (MICCAP) STAMBP CLOVES syndrome PIK3CA somatic Proteus syndrome AKT1 Bannayan-Riley-Ruvalcaba syndrome PTEN CLAPO syndrome PIK3CA Appendix 2-g causal genes of vascular anomalies Abbreviations used Type Alt  for previous view
  • 14. Provisionally unclassified vascular anomalies Verrucous hemangioma / Verrucous VM / Verrucous LVM MAP3K3 somatic Angiokeratoma Sinusoidal hemangioma Acral arteriovenous "tumour" Multifocal lymphangioendotheliomatosis with thrombocytopenia / cutaneovisceral angiomatosis with thrombocytopenia (MLT/CAT) Kaposiform lymphangiomatosis (KLA) PTEN (type) hamartoma of soft tissue / "angiomatosis" of soft tissue PTEN Fibro adipose vascular anomaly (FAVA) PIK3CA Back to overview Appendix 2 -h causal genes of vascular anomalies some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details Type Alt  for previous view
  • 15. Appendix 3 infantile hemangioma Back to overview Pattern - focal - multifocal - segmental - indeterminate Different types - superficial - deep - mixed (superficial + deep) - reticular / abortive / minimal growth - others Association with other lesions PHACE association / syndrome Posterior fossa malformations, Hemangioma, Arterial anomalies, Cardiovascular anomalies, Eye anomalies, sternal clefting and ⁄ or supraumbilical raphe LUMBAR (SACRAL, PELVIS) association / syndrome Lower body hemangioma, Urogenital anomalies, Ulceration, Myelopathy, Bony deformities, Anorectal malformations, Arterial anomalies, and Renal anomalies Type Alt  for previous view
  • 17.
  • 18. IH clinical course markers remain under investigation
  • 19. IH clinical course is not classified and best propranolol timing treatment protocols remain unavailable
  • 21. • FOCAL..RICH ANALOG…GLUT1- • MULTIFOCAL……….GLUT1+ • DIFFUSSE…………...GLUT1+
  • 22. The United Network for Organ Sharing (UNOS) database recorded that a total of 35 children under 1 year of age underwent liver transplantation between 1989 and 2008, because of hemangioma. In contrast, between 2009 and 2017, among 2672 children aged less than 1 year who underwent liver transplantation, none had a diagnosis of hemangioma
  • 23. RICH: Rapidly Involuting Congenital Hemangioma
  • 24.
  • 25.
  • 26.
  • 27.
  • 28. ISSVA classification of vascular tumors II or 2 Locally aggressive or borderline vascular tumors Kaposiform hemangioendothelioma * ° Retiform hemangioendothelioma Papillary intralymphatic angioendothelioma (PILA), Dabska tumor Composite hemangioendothelioma Pseudomyogenic hemangioendothelioma G Polymorphous hemangioendothelioma Hemangioendothelioma not otherwise specified Kaposi sarcoma Others Malignant vascular tumors Angiosarcoma G Epithelioid hemangioendothelioma G Others Back to overview * some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details °many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum rather than distinct entities N.B. reactive proliferative vascular lesions are listed with benign tumors Type Alt  for previous view
  • 31. The spectrum of disease varies greatly between an indolent disease and aggressive disease with widespread metastases. Doyle LA, Fletcher CD, Hornick JL.Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics. Am J Surg Pathol.2016 Jan;40(1):94-102 Uncertain biological behaviour of Composite , Retiform, Epithelioid Hemagioendotheliomas
  • 32. Composite HE : Third recurrence episode
  • 33.
  • 34.
  • 36.
  • 37. 3 years later… metastatic disease
  • 38. Similar clinical course in Pediatric and Adult EHE ? Similar clinical course in liver , skin or pulmonary EHE? Literature review identified 24 children with EHE of the liver/lungs. Most presented with multifocal, systemic disease. Four children experienced rapid progression and died. In six children, disease remained stable for years without therapy. Two patients died from progressive EHE 21 and 24 years after first diagnosis. Twelve surgically excised are free of disease Natural evolution of pediatric visceral EHE is variable, and long-term prognosis remains unclear Hettmer S et al. Epithelioid hemangioendotheliomas of the liver and lung in children and adolescents. Pediatr Blood Cancer.2017 Dec;64(12)
  • 39. Simple vascular malformations I Capillary malformations (CM) Cutaneous and/or mucosal CM (aka “port-wine” stain ) G CM with bone and/or soft tissue overgrowth G CM with CNS and/or ocular anomalies (Sturge-Weber syndrome) CM of CM-AVM G CM of MICCAP (microcephaly-capillary malformation) CM of MCAP (megalencephaly-capillary malformation-polymicrogyria) Telangiectasia Hereditary hemorrhagic telangiectasia (HHT) (different types) G Others Cutis marmorata telangiectatica congenita (CMTC) Nevus simplex / Salmon patch / “angel kiss”, “stork bite” Others ISSVA classification for vascular anomaliesBack to overview clic on G to see genetics Type Alt  for previous view
  • 40.
  • 42.
  • 43.
  • 44. No seizures after 1 year under Sirolimus-AAS treatment Better than expected response to Pulse Dye Laser treatment MOST SEVERE PRESENTATION OF STURGE WEBER SME.
  • 45. Simple vascular malformations II Lymphatic malformations (LM) Common (cystic) LM G Macrocystic LM Microcystic LM Mixed cystic LM Generalized lymphatic anomaly (GLA) LM in Gorham-Stout disease Channel type LM Primary lymphedema (different types) G ISSVA classification for vascular anomalies
  • 46.
  • 47. Infiltration ? Invasion ? Proliferation ? Growth? Enlargement? Dilatation ? “Lymphangiomatosis is a rare disease characterized by diffuse infiltration of lymphangiomas in the lung, bone, and other tissues………” “Diffuse pulmonary lymphangiomatosis has a poor prognosis and is characterized by slow progressive growth of lymphatic……..” “Disseminated lymphangiomatosis is a rare vascular tumor characterized by a proliferation of abnormal lymphatic channels that often involves multiple organ systems………………..” “However, diffuse pulmonary lymphangiomatosis may present as a form of lymphangiectasia, which is characterized pathologically as dilatations of lymphatics without proliferation and without an anastomosing pattern……………………..”
  • 48. AGRESSIVE LYMPHATIC MALFORMATIONS: A PROLIFERATIVE DISORDER ? Meijer-Jorna LB et al. Microvascular proliferation in congenital vascular malformations of skin and soft tissue J Clin Pathol. 2007 July; 60(7): 798–803. “Proliferation does not happen in LM…….” The presence of presumed lymphatic channels in bone that is either hypertrophic or shows progressive disappearance is not associated with increased levels of cell turnover or osteocyte activity ( Paula North, 1st GLA-GSD Conference.Bethesda 2013)
  • 49.
  • 50.
  • 51. VEIN-LYMPHATIC CONNECTION and LYMPHATIC-LYMPHATIC CONNECTION
  • 52.
  • 53. Bilateral LM in neonates have poor prognosis
  • 54.
  • 55.
  • 56. 8 months on Sirolimus
  • 57. 18 months on Sirolimus
  • 58. CHANNEL TYPE LYMPHATIC MALFORMATIONS
  • 60. Simple vascular malformations IIb Primary lymphedema Nonne-Milroy syndrome G Primary hereditary lymphedema G Lymphedema-distichiasis G Hypotrichosis-lymphedema-telangiectasia G Primary lymphedema with myelodysplasia G Primary generalized lymphatic anomaly (Hennekam lymphangiectasia-lymphedema syndrome) G Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome G Lymphedema-choanal atresia G Back to overview ISSVA classification for vascular anomalies clic on G to see genetics Type Alt  for previous view
  • 63. Lymphedema in Sclerosis Tuberosa Complex Lymphedema in Noonan Sme.
  • 65. Simple vascular malformations III Venous malformations (VM) Common VM G Familial VM cutaneo-mucosal (VMCM) G Blue rubber bleb nevus (Bean) syndrome VM G Glomuvenous malformation (GVM) G Cerebral cavernous malformation (CCM) (different types) G Familial intraosseous vascular malformation (VMOS) G Others ISSVA classification for vascular anomalies Back to overview some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details clic on G to see genetics Type Alt  for previous view
  • 66.
  • 67. Caso 1Lopez Gutierrez JC , Ivars M. Fern-shaped patch as a hallmark of blue rubber bleb nevus syndrome in neonatal venous malformations Eur J Pediatr. 2018 Mar 8.
  • 68. Blue Rubber Bleb Nevus Syndrome Tumor or Malformation ?
  • 70.
  • 71. Simple vascular malformations IV Arteriovenous malformations (AVM) Sporadic In HHT G In CM-AVM G Others Arteriovenous fistula (AVF) (congenital) Sporadic In HHT G In CM-AVM G Others ISSVA classification for vascular anomalies Back to overview Abbreviations used clic on G to see genetics Type Alt  for previous view
  • 72.
  • 73.
  • 74.
  • 75. Girón-Vallejo O, López-Gutiérrez JC, Fernández-Pineda I Diagnosis and treatment of Parkes Weber syndrome: a review of 10 consecutive patients. Ann Vasc Surg.2013 Aug;27(6):820-5.
  • 76.
  • 77.
  • 78. 2006
  • 79.
  • 80. ISSVA classification for vascular anomalies Combined vascular malformations* CM + VM capillary-venous malformation CVM CM + LM capillary-lymphatic malformation CLM CM + AVM capillary-arteriovenous malformation CAVM LM + VM lymphatic-venous malformation LVM CM + LM + VM capillary-lymphatic-venous malformation CLVM CM + LM + AVM capillary-lymphatic-arteriovenous malformation CLAVM CM + VM + AVM capillary-venous-arteriovenous malformation CVAVM CM + LM + VM + AVM capillary-lymphatic-venous-arteriovenous m. CLVAVM Back to overview Abbreviations used * defined as two or more vascular malformations found in one lesion Type Alt  for previous view
  • 81. MECHANISMS OF SKELETAL HYPERTROPHY OR ATROPHY IN COMBINED VASCULAR MALFORMATIONS REMAIN UNEXPLAINED Patients with PIK3CA mutations can develope overgrowth, simmetry and undergrowth
  • 82.
  • 83.
  • 85. ORAL PREPARATION FOR CHILDREN UNDER 35 KGS 0’05mg/kg/ 12h 0’4mgs/ml Solution 2´5 mgs tablet in 60ml 5% glucose
  • 86. ISSVA classification for vascular anomalies Back to overview Anomalies of major named vessels (aka "channel type" or "truncal" vascular malformations) Affect lymphatics veins arteries Anomalies of origin course number length diameter (aplasia, hypoplasia, stenosis, ectasia / aneurysm) valves communication (AVF) persistence (of embryonal vessel) Abbreviations used Type Alt  for previous view
  • 87. TGF-β signaling is upregulated in many elastic fiber diseases including Loeys–Dietz, Marfan, and several cutis laxa syndromes but the exact spatio-temporal regulation of TGF-β signaling remains a matter of debate
  • 88. Arterial Tortuosity Syndrome is caused by loss-of-function mutations in the SLC2A10 gene
  • 89.
  • 90. ISSVA classification for vascular anomalies Provisionally unclassified vascular anomalies Verrucous hemangioma, V venous malformation, V veno lymphatic malformation G Angiokeratoma Sinusoidal hemangioma Acral arteriovenous "tumour" Multifocal lymphangioendotheliomatosis with thrombocytopenia / cutaneovisceral angiomatosis with thrombocytopenia (MLT/CAT) Kaposiform lymphangiomatosis (KLA) PTEN (type) hamartoma of soft tissue / "angiomatosis" of soft tissue (PHOST) G Fibro adipose vascular anomaly (FAVA) G Back to overview clic on G to see genetics some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details Type Alt  for previous view
  • 96. CONCLUSIONS Appropiate classification of a VA remains the best way to achieve the expected therapeutical outcome Multidisciplinary interpretation of findings from diagnostic examinations is mandatory and will improve final results A sense of wonder must guide research by the vascular anomalies specialist as many entities remain to be identified , classified and diagnosed.
  • 97. ISSVA classification for vascular anomalies Back to overview Vascular malformations associated with other anomalies Klippel-Trenaunay syndrome: CM + VM +/- LM + limb overgrowth G Parkes Weber syndrome: CM + AVF + limb overgrowth G Servelle-Martorell syndrome: limb VM + bone undergrowth Sturge-Weber syndrome: facial + leptomeningeal CM + eye anomalies +/- bone and/or soft tissue overgrowth G Limb CM + congenital non-progressive limb hypertrophy G Maffucci syndrome: VM +/- spindle-cell hemangioma + enchondroma G Macrocephaly - CM (M-CM / MCAP) G Microcephaly - CM (MICCAP) G CLOVES syndrome: LM + VM + CM +/- AVM + lipomatous overgrowth G Proteus syndrome: CM, VM and/or LM + asymmetrical somatic overgrowth G Bannayan-Riley-Ruvalcaba sd: AVM + VM +macrocephaly, lipomatous overgrowth G CLAPO syndrome: lower lip CM + face and neck LM + asymmetry and partial/generalized overgrowth Abbreviations used clic on G to see genetics Type Alt  for previous view
  • 98. ISSVA classification for vascular anomalies Provisionally unclassified vascular anomalies Verrucous hemangioma, V venous malformation, V veno lymphatic malformation G Angiokeratoma Sinusoidal hemangioma Acral arteriovenous "tumour" Multifocal lymphangioendotheliomatosis with thrombocytopenia / cutaneovisceral angiomatosis with thrombocytopenia (MLT/CAT) Kaposiform lymphangiomatosis (KLA) PTEN (type) hamartoma of soft tissue / "angiomatosis" of soft tissue (PHOST) G Fibro adipose vascular anomaly (FAVA) G Back to overview clic on G to see genetics some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details Type Alt  for previous view
  • 99.
  • 100.
  • 101. Yang CH Orthotopic liver transplant for multifocal lymphangioendotheliomatosis with thrombocytopenia. Pediatr Transplant.2016 May;20(3):456-459.
  • 102. Appendix 4 vascular anomalies possibly associated with platelet count / coagulation disorders Back to overview Anomalies Hematological disorders Tufted angioma Kaposiform hemangioendothelioma Profound and sustained thrombocytopenia with profound hypofibrinogenemia, consumptive coagulopathy and elevated D-dimer (Kasabach-Merritt phenomenon) Rapidly involuting congenital hemangioma Transient mild/moderate thrombocytopenia, +/- consumptive coagulopathy and elevated D-dimer Venous malformations / Lymphatic-venous malformations Chronic localized intravascular coagulopathy with elevated D-dimer, +/- hypofibrinogenemia, and +/- moderate thrombocytopenia (may progress to DIC after trauma or operation) Lymphatic malformations Chronic localized intravascular coagulopathy with elevated D-dimer and +/- mild to moderate thrombocytopenia (consider Kaposiform lymphangiomatosis) (may progress to DIC after trauma or operation) Multifocal lymphangioendotheliomatosis with thrombocytopenia / Cutaneovisceral angiomatosis with thrombocytopenia Sustained, fluctuating, moderate to profound thrombocytopenia with gastrointestinal tract bleeding or pulmonary hemorrhage Kaposiform lymphangiomatosis Mild to Moderate thrombocytopenia, +/- hypofibrinogenemia, and D-dimer elevation Type Alt  for previous view
  • 103. Appendix 1 abbreviations used (excluding gene names) Back to overview AVF arteriovenous fistula AVM arteriovenous malformation CAT cutaneovisceral angiomatosis with thrombocytopenia CAVM capillary arteriovenous malformation CCM cerebral cavernous malformation CLAVM capillary lymphatic arteriovenous malformation CLAPO lower lip CM + face and neck LM + asymmetry and partial/generalized overgrowth CLOVES congenital lipomatous overgrowth, vascular malformations, epidermal nevi, skeletal/scoliosis and spinal abnormalities CLM capillary lymphatic malformation CLVAVM capillary lymphatic venous arteriovenous malformation CLVM capillary lymphatic venous malformation CM capillary malformation CM-AVM capillary malformation-arteriovenous malformation CMTC cutis marmorata telangiectatica congenita CNS central nervous system CVAVM capillary venous arteriovenous malformation CVM capillary venous malformation DIC disseminated intravascular coagulopathy FAVA Fibro adipose vascular anomaly GLA generalized lymphatic anomaly GSD Gorham-Stout disease GVM glomuvenous malformation HHT hereditary hemorrhagic telangiectasia HI hemangioma of infancy / infantile hemangioma IH infantile hemangioma / hemangioma of infancy INR international normalized ratio JPHT juvenile polyposis hemorrhagic telangiectasia KHE kaposiform hemangioendothelioma KLA kaposiform lymphangiomatosis KMP Kasabach-Merritt phenomenon, LM lymphatic malformation LVM lymphatic venous malformation MCAP megalencephaly-capillary malformation-polymicrogyria M-CM macrocephaly-capillary malformation MICCAP microcephaly-capillary malformation MLT Multifocal lymphangioendotheliomatosis with thrombocytopenia NICH non-involuting congenital hemangioma PHACE posterior fossa malformations, hemangioma, arterial anomalies, cardiovascular anomalies, eye anomalies PHOST PTEN hamartoma of soft tissue PILA papillary intralymphatic angioendothelioma PICH partially involuting congenital hemangioma RICH rapidly involuting congenital hemangioma TA tufted angioma VM venous malformation VMCM venous malformation cutaneo mucosal Type Alt  for previous view
  • 104. Benign vascular tumors Congenital hemangioma GNAQ / GNA11 Rapidly involuting (RICH) * Non-involuting (NICH) Partially involuting (PICH) Epithelioid hemangioma FOS Spindle-cell hemangioma IDH1 / IDH2 Locally aggressive or borderline vascular tumors Kaposiform hemangioendothelioma t(13;16)(q14;p13.3) Pseudomyogenic hemangioendothelioma t(7:19)(q22;13) FOSB Malignant vascular tumors Angiosarcoma (post radiation) MYC Epithelioid hemangioendothelioma CAMTA1 / TFE3 Back to overview Type Alt  for previous viewAppendix 2-a causal genes of vascular anomalies
  • 105. Capillary malformations (CM) Cutaneous and/or mucosal CM (aka “port-wine” stain ) GNAQ CM with bone and/or soft tissue hyperplasia GNA11 CM with CNS and/or ocular anomalies (Sturge-Weber syndrome) GNAQ CM of CM-AVM RASA1 / EPHB4 Telangiectasia Hereditary hemorrhagic telangiectasia (HHT) HHT1 ENG HHT2 ACVRL1 HHT3 JPHT (juvenile polyposis hemorrhagic telangiectasia) SMAD4 Others Cutis marmorata telangiectatica congenita (CMTC) Nevus simplex / Salmon patch Others Appendix 2-b causal genes of vascular anomalies Back to overview Type Alt  for previous view
  • 106. Simple vascular malformations II Lymphatic malformations (LM) Common (cystic) LM PIK3CA? Macrocystic LM Microcystic LM Mixed cystic LM Generalized lymphatic anomaly (GLA) LM in Gorham-Stout disease Channel type LM Primary lymphedema (different types) G Acquired progressive lymphatic anomaly (benign "lymphangioendothelioma") Others Back to overview some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details clic on G to see genetics Type Alt  for previous viewAppendix 2-c causal genes of vascular anomalies
  • 107. Lymphatic malformations (LM) Primary lymphedema Nonne-Milroy syndrome FLT4 / VEGFR3 Primary hereditary lymphedema VEGFC Primary hereditary lymphedema GJC2 / Connexin 47 Lymphedema-distichiasis FOXC2 Hypotrichosis-lymphedema-telangiectasia SOX18 Primary lymphedema with myelodysplasia GATA2 Primary generalized lymphatic anomaly (Hennekam lymphangiectasia-lymphedema syndrome) CCBE1 Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome KIF11 Lymphedema-choanal atresia PTPN14 Back to overview Appendix 2-d causal genes of vascular anomalies Type Alt  for previous view
  • 108. Venous malformations (VM) Common VM TEK (TIE2) / PIK3CA somatic Familial VM cutaneo-mucosal (VMCM) TEK (TIE2) Blue rubber bleb nevus (Bean) syndrome VM TEK somatic Glomuvenous malformation (VM with glomus cells) Glomulin Cerebral cavernous malformation (CCM) CCM1 KRIT1 CCM2 Malcavernin CCM3 PDCD10 Familial intraosseous vascular malformation (VMOS) ELMO2 Back to overview Appendix 2-e causal genes of vascular anomalies Type Alt  for previous view
  • 109. Arteriovenous malformations (AVM) Sporadic In HHT HHT1 ENG HHT2 ACVRL1 JPHT (juvenile polyposis hem. telangiect.) SMAD4 In CM-AVM RASA1 / EPHB4 Arteriovenous fistulas (AVF) Sporadic In HHT HHT1 ENG HHT2 ACVRL1 JPHT (juvenile polyposis hemorrhagic telangiectasia) SMAD4 In CM-AVM RASA1 / EPHB4 Back to overview Appendix 2-f causal genes of vascular anomalies Abbreviations used Type Alt  for previous view
  • 110. Back to overview Vascular malformations associated with other anomalies Klippel-Trenaunay syndrome PIK3CA Parkes Weber syndrome RASA1 Servelle-Martorell syndrome Sturge-Weber syndrome GNAQ Limb CM + congenital non-progressive limb overgrowth GNA11 Maffucci syndrome IDH1 / IDH2 / NPM1 Macrocephaly - CM (M-CM or MCAP) PIK3CA Microcephaly - CM (MICCAP) STAMBP CLOVES syndrome PIK3CA Proteus syndrome AKT1 Bannayan-Riley-Ruvalcaba syndrome PTEN CLAPO syndrome Appendix 2-g causal genes of vascular anomalies Abbreviations used Type Alt  for previous view
  • 111. Provisionally unclassified vascular anomalies Verrucous hemangioma / V venous malformation / V veno lymphatic malformation MAP3K3 somatic Angiokeratoma Sinusoidal hemangioma Acral arteriovenous "tumour" Multifocal lymphangioendotheliomatosis with thrombocytopenia / cutaneovisceral angiomatosis with thrombocytopenia (MLT/CAT) Kaposiform lymphangiomatosis (KLA) PTEN (type) hamartoma of soft tissue / "angiomatosis" of soft tissue PTEN Fibro adipose vascular anomaly PIK3CA Back to overview Appendix 2 -h causal genes of vascular anomalies some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details Type Alt  for previous view
  • 112. * some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details °many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum rather than distinct entities N.B. reactive proliferative vascular lesions are listed with benign tumors ISSVA classification of vascular tumors 1a Benign vascular tumors 1 Infantile hemangioma / Hemangioma of infancy see details Congenital hemangioma G Rapidly involuting (RICH) * Non-involuting (NICH) Partially involuting (PICH) Tufted angioma * ° Spindle-cell hemangioma G Intramuscular hemangioma (capillary type) Epithelioid hemangioma G Pyogenic granuloma (aka lobular capillary hemangioma) Others see details Back to overview Type Alt  for previous view
  • 113. N.B. reactive proliferative vascular lesions are listed with benign tumors ISSVA classification of vascular tumors 1b Benign vascular tumors 2 Others Honail hemangioma Microvenular hemangioma Anastomosing hemangioma Glomeruloid hemangioma Papillary hemangioma Intravascular papillary endothelial hyperplasia Cutaneous epitheliod angiomatous nodule Acquired elastotic hemangioma Littoral cell hemangioma of the spleen Related lesions Eccrine angiomatous hamartoma Reactive angioendotheliomatosis Bacillary angiomatosis Back to overview Type Alt  for previous view
  • 114. ISSVA classification for vascular anomalies (Approved at the 20th ISSVA Workshop, Melbourne, April 2014) Overview table °defined as two or more vascular malformations found in one lesion * high-flow lesions N.B. The classification tables do not list exhaustively all known vascular anomalies. Some rare "dermatologic" vascular anomalies will be found in dermatology textbooks. The tumor or malformation nature or precise classification of some lesions is still unclear. These lesions appear in a separate provisional list. Vascular anomalies Vascular tumors Vascular malformations Simple Combined ° of major named vessels associated with other anomalies Benign Locally aggressive or borderline Malignant Capillary malformations Lymphatic malformations Venous malformations Arteriovenous malformations* Arteriovenous fistula* CVM, CLM LVM, CLVM CAVM* CLAVM* others See details See list For more details, click on the underlined linksAbbreviations used
  • 115. * some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details °many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum rather than distinct entities N.B. reactive proliferative vascular lesions are listed with benign tumors ISSVA classification of vascular tumors 1a Benign vascular tumors 1 Infantile hemangioma / Hemangioma of infancy see details Congenital hemangioma G Rapidly involuting (RICH) * Non-involuting (NICH) Partially involuting (PICH) Tufted angioma * ° Spindle-cell hemangioma G Intramuscular hemangioma (capillary type) Epithelioid hemangioma G Pyogenic granuloma (aka lobular capillary hemangioma) Others see details Back to overview Type Alt  for previous view
  • 116. N.B. reactive proliferative vascular lesions are listed with benign tumors ISSVA classification of vascular tumors 1b Benign vascular tumors 2 Others Hobnail hemangioma Microvenular hemangioma Anastomosing hemangioma Glomeruloid hemangioma Papillary hemangioma Intravascular papillary endothelial hyperplasia Cutaneous epitheliod angiomatous nodule Acquired elastotic hemangioma Littoral cell hemangioma of the spleen Related lesions Eccrine angiomatous hamartoma Reactive angioendotheliomatosis Bacillary angiomatosis Back to overview Type Alt  for previous view
  • 117. ISSVA classification of vascular tumors I Benign vascular tumors Infantile hemangioma / Hemangioma of infancy see details Congenital hemangioma Rapidly involuting (RICH) *, Non-involuting (NICH), Partially involuting (PICH) Tufted angioma * ° Spindle-cell hemangioma Intramuscular hemangioma (capillary type) Epithelioid hemangioma Pyogenic granuloma (aka lobular capillary hemangioma) Others Honail hemangioma Microvenular hemangioma Anastomosing hemangioma Glomeruloid hemangioma Papillary hemangioma Intravascular papillary endothelial hyperplasia Cutaneous epitheliod angiomatous nodule Acquired elastotic hemangioma Littoral cell hemangioma of the spleen Related lesions Eccrine angiomatous hamartoma Reactive angioendotheliomatosis Bacillary angiomatosis Back to overview Type Alt  for previous view * some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details °many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum rather than distinct entities N.B. reactive proliferative vascular lesions are listed with benign tumors
  • 118. ISSVA classification of vascular tumors II or 2 Locally aggressive or borderline vascular tumors Kaposiform hemangioendothelioma * ° Retiform hemangioendothelioma Papillary intralymphatic angioendothelioma (PILA), Dabska tumor Composite hemangioendothelioma Pseudomyogenic hemangioendothelioma G Polymorphous hemangioendothelioma Hemangioendothelioma not otherwise specified Kaposi sarcoma Others Malignant vascular tumors Angiosarcoma G Epithelioid hemangioendothelioma G Others Back to overview * some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details °many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum rather than distinct entities N.B. reactive proliferative vascular lesions are listed with benign tumors Type Alt  for previous view
  • 119. Simple vascular malformations I Capillary malformations (CM) Cutaneous and/or mucosal CM (aka “port-wine” stain ) G CM with bone and/or soft tissue overgrowth G CM with CNS and/or ocular anomalies (Sturge-Weber syndrome) CM of CM-AVM G CM of MICCAP (microcephaly-capillary malformation) CM of MCAP (megalencephaly-capillary malformation-polymicrogyria) Telangiectasia Hereditary hemorrhagic telangiectasia (HHT) (different types) G Others Cutis marmorata telangiectatica congenita (CMTC) Nevus simplex / Salmon patch / “angel kiss”, “stork bite” Others ISSVA classification for vascular anomaliesBack to overview clic on G to see genetics Type Alt  for previous view
  • 120. Simple vascular malformations II Lymphatic malformations (LM) Common (cystic) LM G Macrocystic LM Microcystic LM Mixed cystic LM Generalized lymphatic anomaly (GLA) LM in Gorham-Stout disease Channel type LM Primary lymphedema (different types) G Acquired progressive lymphatic anomaly (benign "lymphangioendothelioma") Others ISSVA classification for vascular anomalies Back to overview some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details clic on G to see genetics Type Alt  for previous view
  • 121. Simple vascular malformations IIb Primary lymphedema Nonne-Milroy syndrome G Primary hereditary lymphedema G Lymphedema-distichiasis G Hypotrichosis-lymphedema-telangiectasia G Primary lymphedema with myelodysplasia G Primary generalized lymphatic anomaly (Hennekam lymphangiectasia-lymphedema syndrome) G Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome G Lymphedema-choanal atresia G Back to overview ISSVA classification for vascular anomalies clic on G to see genetics Type Alt  for previous view
  • 122. Simple vascular malformations III Venous malformations (VM) Common VM G Familial VM cutaneo-mucosal (VMCM) G Blue rubber bleb nevus (Bean) syndrome VM G Glomuvenous malformation (GVM) G Cerebral cavernous malformation (CCM) (different types) G Familial intraosseous vascular malformation (VMOS) G Others ISSVA classification for vascular anomalies Back to overview some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details clic on G to see genetics Type Alt  for previous view
  • 123. Simple vascular malformations IV Arteriovenous malformations (AVM) Sporadic In HHT G In CM-AVM G Others Arteriovenous fistula (AVF) (congenital) Sporadic In HHT G In CM-AVM G Others ISSVA classification for vascular anomalies Back to overview Abbreviations used clic on G to see genetics Type Alt  for previous view
  • 124. ISSVA classification for vascular anomalies Combined vascular malformations* CM + VM capillary-venous malformation CVM CM + LM capillary-lymphatic malformation CLM CM + AVM capillary-arteriovenous malformation CAVM LM + VM lymphatic-venous malformation LVM CM + LM + VM capillary-lymphatic-venous malformation CLVM CM + LM + AVM capillary-lymphatic-arteriovenous malformation CLAVM CM + VM + AVM capillary-venous-arteriovenous malformation CVAVM CM + LM + VM + AVM capillary-lymphatic-venous-arteriovenous m. CLVAVM Back to overview Abbreviations used * defined as two or more vascular malformations found in one lesion Type Alt  for previous view
  • 125. ISSVA classification for vascular anomalies Back to overview Anomalies of major named vessels (aka "channel type" or "truncal" vascular malformations) Affect lymphatics veins arteries Anomalies of origin course number length diameter (aplasia, hypoplasia, stenosis, ectasia / aneurysm) valves communication (AVF) persistence (of embryonal vessel) Abbreviations used Type Alt  for previous view
  • 126. ISSVA classification for vascular anomalies Back to overview Vascular malformations associated with other anomalies Klippel-Trenaunay syndrome: CM + VM +/- LM + limb overgrowth G Parkes Weber syndrome: CM + AVF + limb overgrowth G Servelle-Martorell syndrome: limb VM + bone undergrowth Sturge-Weber syndrome: facial + leptomeningeal CM + eye anomalies +/- bone and/or soft tissue overgrowth G Limb CM + congenital non-progressive limb hypertrophy G Maffucci syndrome: VM +/- spindle-cell hemangioma + enchondroma G Macrocephaly - CM (M-CM / MCAP) G Microcephaly - CM (MICCAP) G CLOVES syndrome: LM + VM + CM +/- AVM + lipomatous overgrowth G Proteus syndrome: CM, VM and/or LM + asymmetrical somatic overgrowth G Bannayan-Riley-Ruvalcaba sd: AVM + VM +macrocephaly, lipomatous overgrowth G CLAPO syndrome: lower lip CM + face and neck LM + asymmetry and partial/generalized overgrowth Abbreviations used clic on G to see genetics Type Alt  for previous view
  • 127. Appendix 1 abbreviations used (excluding gene names) Back to overview AVF arteriovenous fistula AVM arteriovenous malformation CAT cutaneovisceral angiomatosis with thrombocytopenia CAVM capillary arteriovenous malformation CCM cerebral cavernous malformation CLAVM capillary lymphatic arteriovenous malformation CLAPO lower lip CM + face and neck LM + asymmetry and partial/generalized overgrowth CLOVES congenital lipomatous overgrowth, vascular malformations, epidermal nevi, skeletal/scoliosis and spinal abnormalities CLM capillary lymphatic malformation CLVAVM capillary lymphatic venous arteriovenous malformation CLVM capillary lymphatic venous malformation CM capillary malformation CM-AVM capillary malformation-arteriovenous malformation CMTC cutis marmorata telangiectatica congenita CNS central nervous system CVAVM capillary venous arteriovenous malformation CVM capillary venous malformation DIC disseminated intravascular coagulopathy FAVA Fibro adipose vascular anomaly GLA generalized lymphatic anomaly GSD Gorham-Stout disease GVM glomuvenous malformation HHT hereditary hemorrhagic telangiectasia HI hemangioma of infancy / infantile hemangioma IH infantile hemangioma / hemangioma of infancy INR international normalized ratio JPHT juvenile polyposis hemorrhagic telangiectasia KHE kaposiform hemangioendothelioma KLA kaposiform lymphangiomatosis KMP Kasabach-Merritt phenomenon, LM lymphatic malformation LVM lymphatic venous malformation MCAP megalencephaly-capillary malformation-polymicrogyria M-CM macrocephaly-capillary malformation MICCAP microcephaly-capillary malformation MLT Multifocal lymphangioendotheliomatosis with thrombocytopenia NICH non-involuting congenital hemangioma PHACE posterior fossa malformations, hemangioma, arterial anomalies, cardiovascular anomalies, eye anomalies PHOST PTEN hamartoma of soft tissue PILA papillary intralymphatic angioendothelioma PICH partially involuting congenital hemangioma RICH rapidly involuting congenital hemangioma TA tufted angioma VM venous malformation VMCM venous malformation cutaneo mucosal Type Alt  for previous view
  • 128. Appendix 3 infantile hemangioma Back to overview Pattern - focal - multifocal - segmental - indeterminate Different types - superficial - deep - mixed (superficial + deep) - reticular / abortive / minimal growth - others Association with other lesions PHACE association / syndrome Posterior fossa malformations, Hemangioma, Arterial anomalies, Cardiovascular anomalies, Eye anomalies, sternal clefting and ⁄ or supraumbilical raphe LUMBAR (SACRAL, PELVIS) association / syndrome Lower body hemangioma, Urogenital anomalies, Ulceration, Myelopathy, Bony deformities, Anorectal malformations, Arterial anomalies, and Renal anomalies Type Alt  for previous view
  • 130.
  • 131.
  • 132.
  • 133. No response to Sirolimus Response to Vincristine –Ticlopidine – Aspirine and percutaneous biliary diversion Triana PJ, Lopez Gutierrez JC Pancreatic Kaposiform Hemangioendothelioma Not Responding to Sirolimus. European Journal of Pediatric Surgery. 2017;5(1).